Effect of Tim23 Knockdown IN VIVO on Protein Import into Mitochondria and Retrograde Signaling to the UPRmt in Muscle by Oliveira, Ashley Nicole Estima
 
 
 
EFFECT OF TIM23 KNOCKDOWN IN VIVO ON PROTEIN IMPORT 
INTO MITOCHONDRIA AND RETROGRADE SIGNALING TO THE 
UPRMT IN MUSCLE 
 
 
 
 
ASHLEY N. OLIVEIRA 
 
 
 
 
 
A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE OF  
 
 
 
MASTER OF SCIENCE 
 
 
 
 
 
GRADUATE PROGRAM IN KINESIOLOGY AND HEALTH SCIENCE 
 
 
YORK UNIVERSITY 
TORONTO, ONTARIO 
 
 
 
 
 
SEPTEMBER 2017 
 
 
© ASHLEY OLIVEIRA, 2017 
  
		
	 ii	
ABSTRACT 
The mitochondrial unfolded protein response (UPRmt) is a protein quality control 
mechanism that strives to eliminate toxic effects exerted by misfolded and misassembled 
proteins. We sought to understand this mechanism by perturbing the coordination between the 
nuclear and mitochondrial genomes by reducing the expression of a major channel of the inner 
mitochondrial membrane. This established a relationship between protein import, and the 
maintenance of mitochondrial proteostasis. Next, we sought to explore the communication 
between the nucleus and the mitochondrion that mediates the activation of the UPRmt. We 
investigated the role for proteolytically-derived peptides in this retrograde signaling. Here we 
highlight the relationship between the protein import pathway and its role in facilitating peptide-
mediated communication in maintaining proteostasis. The UPRmt has been implicated in aging, 
cancer, and neurodegenerative diseases. Thus, my work has contributed to improving our 
understanding of this quality control mechanism, thereby providing potential future therapeutic 
targets.  
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CHAPTER 1: REVIEW OF LITERATURE 
 
1.0 SKELETAL MUSCLE PHYSIOLOGY 
 
Skeletal muscle comprises approximately 40-50% of an individual’s body mass and is a 
highly metabolic organ. Apart from its essential role in providing postural support and movement 
for the organism, it also plays a key role in metabolism (46). In order to understand the 
maintenance and the plasticity of skeletal muscle, it is important to first examine the constituents 
that form this complex organ system. Muscle cells are unique in their long cylindrical structure 
and their multinucleated composition, whereby nuclei are arranged under the sarcolemma in the 
periphery of the cells. Each muscle cell contains specialized contractile elements such as myosin 
and actin filaments that are organized into repeating sarcomeres. Through the physical 
interaction of myosin and actin, skeletal muscle is able to contract in an ATP-dependent manner. 
Despite these basic properties, there is a vast amount of heterogeneity in skeletal muscle fibers, 
which are typically classified based on their biochemical, mechanical and metabolic properties. 
These differences contribute to varying performance capacities as well as the fiber’s ability to 
adapt (24, 68). Overall, skeletal muscle maintenance and plasticity is well characterized, 
however the underlying mechanisms that mediate this processes have yet to be fully elucidated.  
1.1 Skeletal Muscle Fiber Types 
Historically, skeletal muscle has been divided into three sub-classes based on the 
expression of myosin heavy chain isoform, typically determined via histochemical analyses. The 
standard classification of skeletal muscle is as follows: 1) slow-twitch red (STR) fibers 
predominately expressing myosin heavy chain (MHC) type I isoform, 2) fast-twitch red (FTR) 
fibers containing mostly MHC type II isoform, and 3) fast-twitch white (FTW) comprised of 
either MHC type IIa or IIb, depending on species. Each fiber type contains a distinct profile of 
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contractile and metabolic properties contributing to their particular phenotype (105). Type I or 
STR fibers have slower twitch kinetics, meaning longer time to peak tension and longer 
relaxation times (104, 105). This makes the fiber more economical with the use of ATP and more 
resistant to fatigue (109). STR fibers are also highly oxidative and rely heavily on mitochondria 
for their source of ATP (97). Although these fibers have very low force outputs they are, 
however, well suited for prolonged submaximal exercise (104, 105). Type IIa or FTR fibers have 
faster twitch kinetics and maintain a fairly oxidative metabolic profile. Type IIb/x or FTW fibers 
produce the most amount of force due to rapid twitch kinetics however, they also require more 
ATP (103–105). Type IIb/x fibers are highly glycolytic, which in turn makes them very 
susceptible to fatigue due to the inefficient generation of ATP and the intramuscular production 
of lactic acid. The heterogeneity in various biochemical, metabolic and contractile properties 
contribute to the different phenotypes observed in the three muscle fiber types.  
Recently, histology has proven insufficient to fully characterize the complexity of a 
single muscle fiber. Through the use of single fiber electrophoresis, fiber hybridization has 
complicated the simple categorization of muscle fibers transforming it into more of a spectrum in 
which hybrid fibers exist as intermediates of the three traditional sub-classes (48, 53). Fibers 
expressing all three MHC isoforms have been documented in both human and rodent models 
(119). It has been proposed that these hybrid fibers are in transition and are in the process of a 
fiber type switch, however the significance of these fibers is still unclear (91). Muscle groups are 
not composed of a single fiber type, but rather a mosaic of all fiber types contributing to the 
complexity and heterogeneity of a single muscle.  
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1.2 Mitochondrial Subfractions  
ATP, the energy currency of the cell, is of the utmost importance for the function and 
maintenance of the cell and is primarily derived from mitochondrial respiration. Skeletal muscle 
is no exception, and thus mitochondria are imperative for skeletal muscle performance and are 
tightly associated with endurance capacity. Mitochondria are structurally unique organelles in 
that they maintain two intra-organelle sub-compartments separated by phospholipid membranes. 
The mitochondrial matrix is encapsulated by the inner membrane, and located within are 
multiple copies of mitochondrial DNA (mtDNA). Encoded within this genome are 22 tRNAs, 2 
rRNAs, and 13 components of the electron transport chain, which are transcribed and translated 
within the mitochondrial matrix (14). The mitochondrial genome provides for less than 1% of all 
mitochondrial proteins, the vast majority of which are encoded by the nuclear genome. 
Mitochondria are the only organelle that rely on two genomes and thus require a mechanism for 
the transport of nuclear-encoded proteins and to maintain proper stoichiometry between both 
genomes. These processes will be further discussed in a later section.  
The inner membrane not only encapsulates the matrix but also houses the five complexes 
necessary for the electron transport chain. Briefly, the electron transport chain is responsible for 
carrying out mitochondrial respiration by reducing various substrates such as NADH and FADH2 
and moving their electrons through the various complexes. Movement of these electrons through 
the complexes generates energy that is used to pump protons from the mitochondrial matrix into 
the intermembrane space creating a proton motive force (PMF) (74). At complex IV, oxygen 
then acts as the final electron acceptor and combines with hydrogen to produce water. The 
electrochemical gradient produced by the buildup of protons in the intermembrane space is 
capitalized on by ATP synthase, which allows a single proton to move back into the matrix (74).  
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The free energy from the movement of the proton is transformed into chemical energy used to 
convert ADP into ATP (74). Thus, through various reduction-oxidation (redox) reactions, the 
mitochondrion is able to exploit this energy to generate large amount of ATP for the cell.  
Mitochondria exist as interconnected networks known as the mitochondrial reticulum 
(57, 83). The reticulum is maintained through highly regulated events of fusion and fission in 
which mitochondria can combine to promote the expansion of the network, or conversely, 
dysfunctional areas can be selectively removed through fission (120). Larger, more 
interconnected mitochondria promote the movement and sharing of substrates along the network 
thus making the reticulum as a whole more efficient (35). On the other hand, small fragmented 
mitochondria produce large amounts of reactive oxygen species (ROS), which are toxic to the 
cell. These smaller, harmful organelles can be removed by the process of mitophagy, which will 
be discussed later. Thus it is imperative for the mitochondrial reticulum to continuously undergo 
fusion and fission events in order to maintain a healthy and optimal pool.  
Within skeletal muscle, mitochondria exist in two subfractions: subsarcolemmal (SS) and 
intermyofibrillar (IMF) mitochondria. These two pools of mitochondria are distinguished by 
their subcellular localization, whereby SS are located along the periphery under the sarcolemmal 
membrane, and IMF are found between the myofibrils. These separate populations have related, 
yet distinct functional and biochemical characteristics. Due to their location, it is proposed that 
SS mitochondria are responsible for providing energy for nuclear and membrane functions. IMF 
mitochondria are primarily responsible for providing energy for actin and myosin crossbridge 
cycling and contractions. IMF mitochondria make up about 80-85% of the total mitochondrial 
volume and exhibit higher rates of mitochondrial respiration, protein synthesis and protein 
import (20, 117). On the other hand, SS mitochondria tend to produce more reactive oxygen 
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species (ROS) and display higher membrane potentials. Thus, due to their distinct subcellular 
localization and differences in biochemical and metabolic properties, these two populations 
respond differently to external stimuli. In models of exercise training or muscle disuse, SS 
mitochondria exhibit more robust adaptation and have therefore thought to be more labile (48). 
The health and maintenance of both pools are required for skeletal muscle health.  
1.3 Mitochondrial Turnover 
Mitochondria are crucial organelles for their roles in metabolism, calcium handling, 
regulation of apoptosis and reactive oxygen species production/ signaling. Two opposing 
processes govern the balance of mitochondria: mitochondrial biogenesis, the synthesis of new 
organelles, and mitophagy, the selective recycling of these organelles (44). Mitochondrial 
biogenesis and mitophagy were once thought to be independent and opposing processes, 
however it has recently been shown that these mechanisms are actually correlated and 
coordinated in order to maintain a healthy mitochondrial population (106, 123, 125). Both 
mitochondrial biogenesis and mitophagy are crucial for the overall health of the muscle (13, 15, 
28, 70, 71).  
1.3.1 Mitochondrial Biogenesis 
Mitochondrial biogenesis is broadly described as the synthesis of new mitochondria, 
however it is important to note that these organelles cannot be formed de novo but rather are 
added to the pre-existing reticulum. Therefore, mitochondrial biogenesis refers to the process 
through which the nuclear and mitochondrial genomes are coordinated to increase the expression 
of mitochondrial proteins, which then expand the network (45, 101, 102). Peroxisome 
proliferator-activated receptor (PPAR)-γ coactivator (PGC-1α) is widely known as the master 
regulator of mitochondrial biogenesis, this is due to the fact that once activated it promotes the 
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transcription of nuclear genes encoding mitochondrial proteins (NuGEMPs). PGC-1α 
concurrently increases the transcription of mitochondrial transcription factor A (TFAM), which 
then acts on mtDNA to increase the transcription of mitochondrial-encoded components of the 
electron transport chain (37). However, PGC-1α is incapable of binding DNA directly and thus 
regulates mitochondrial biogenesis by coactivating transcription factors such as nuclear 
respiratory factor 1/2 (NRF1/2), the PPAR family, estrogen-related receptors (ERRα/β/γ) and 
many others (30). Despite its name as the master regulator, PGC-1α does not seem to be required 
for mitochondrial biogenesis since PGC-1α knockout animals are able to reap similar exercise-
mediated mitochondrial adaptations (65, 99, 122). Therefore, the evidence points towards other 
compensatory mechanisms that may have similar roles as PGC-1α in mediating mitochondrial 
biogenesis.  
Despite being the only organelle aside from the nucleus that contains its own genome, 
mtDNA encodes for less than 1% of all mitochondrial proteins. Therefore the vast majority of 
mitochondrial proteins are transcribed from the nuclear genome and thus translated in the 
cytosol. All products of NuGEMPs contain a mitochondrial targeting sequence (MTS) that is 
recognized by cytosolic chaperones that unfold and guide the immature protein to the protein 
import machinery (PIM) (11, 27). The PIM is primarily composed of the translocases of the 
outer and inner membrane (TOM and TIM complexes, respectively), which rely on ATP and 
membrane potential to move linearized proteins into the organelle. Once the nuclear-encoded 
protein arrives in its designated subcompartment, the MTS is cleaved off by mitochondrial 
processing peptidase (MPP) and refolded by mitochondrial chaperones assuming its mature 
conformation. All of the complexes of the ETC, besides complex II, require both nuclear and 
mitochondrial-encoded proteins in order to form a mature holoenzyme. Thus, mitochondrial 
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biogenesis is not just a matter of transcriptional upregulation, but also a coordinated expression 
between the two genomes in order to maintain proper ETC stoichiometry.   
Mitochondrial biogenesis is not a static process; it is a dynamic and metabolically 
sensitive pathway that contributes to the overall oxidative capacity of the tissue. It is widely 
accepted that endurance exercise induces mitochondrial biogenesis, and even one bout can 
initiate the signals and changes in gene expression (1, 5, 92). Exercise imposes a metabolic 
demand on the tissue that causes changes in energy status, Ca2+ homeostasis, and ROS 
generation, among many others (12, 16, 25). These alterations to the cellular environment 
activate AMP-activated protein kinase (AMPK) (29, 49, 50, 128), Ca2+/ calmodulin-dependent 
kinase (CaMK) (25), and mitogen-activated protein kinase (p38 MAPK) (93, 94), sirtuins 
(SIRT1/3) (4, 36) which all converge on PGC-1α activation to drive mitochondrial biogenesis. In 
contrast, there are conditions that suppress mitochondrial biogenesis, such as aging. Although 
somewhat controversial, aging is associated with lower levels of mitochondrial content and a 
dampened ability to adapt to stressors such as exercise (69). Understanding the molecular 
mechanisms that underlie the regulation of mitochondrial biogenesis is imperative, however this 
process is opposed by the degradation of mitochondria. Thus, it is important to understand both 
mechanisms independently, as well as how they cooperate to maintain homeostasis.  
1.3.2 Mitophagy  
The maintenance of mitochondrial quality requires not only the synthesis of new 
mitochondria but also the degradation of old and damaged organelles. The process of recycling 
dysfunctional mitochondria is termed mitophagy, meaning a form of mitochondria-specific 
autophagy (75). Organelles that have lost their viability typically display an elevation in reactive 
oxygen species (ROS) production and a loss in membrane potential, which serve as signals to 
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target their sequestration and subsequent degradation (23, 127). Segments of the mitochondrial 
reticulum that display this loss in membrane potential or elevation in ROS can undergo fission 
which is the process through which a dysfunctional portion can be excised from the network to 
ensure the overall health of the reticulum (32). In this process, mitochondrial fission protein 1 
(Fis1) recruits and binds dynamin-related protein 1 (Drp1), which pinches off the membrane of 
the damaged organelle removing it from the network. Once sequestered, the fragmented 
organelle can be recycled without interfering with the existing reticulum.  
Following the budding off of the dysfunctional mitochondrion, the organelle can be 
targeted for recycling through mitophagy. There are various mechanisms through which 
mitophagy is thought to be initiated (127). In the canonical pathway, PTEN-induced putative 
kinase 1 (PINK1), a protein kinase that is regularly imported into the matrix and degraded 
accumulates on the outer mitochondrial membrane (72, 124). PINK1 accumulation recruits 
Parkin, an E3 ubiquitin ligase that polyubiquitinates various outer mitochondrial proteins such as 
MFN1/2 and VDAC (34, 72, 78). Ubiquitin chains act as a flag to signal for the engulfment of 
the organelle in a lipid membrane containing LC3-II bound via the adaptor protein p62 (34). 
Once fully engulfed, it is now referred to as the autophagosome, which travels along microtubule 
tracts to the lysosome. The autophagosome can then fuse with the lysosome, creating the 
autophagolysosome, which degrades its contents through proteolytic enzymes and a low pH (75). 
The cargo is subsequently broken down into its basic amino acids and these are released into the 
cytosol where they can be used for later protein synthesis.  
Alternatively, mitophagy can be initiated independent of PINK1 and Parkin, in receptor-
mediated pathways. BCL2/ adenovirus E1B interacting protein (BNIP3) and NIX are both 
receptors found on the outer mitochondrial membrane, previously described for their roles in 
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apoptosis, have recently been shown to flag dysfunctional organelles for degradation (8, 64). 
Both BNIP3 and NIX both contain LC3 interacting domains, which allow the engulfment of the 
damaged organelle by the growing autophagosome (132). Therefore, mitophagy is a complex 
process that can be initiated by several independent pathways that strives to recycle 
dysfunctional mitochondria in an attempt to preserve the mitochondrial reticulum.  
Similar to mitochondrial biogenesis, mitophagy can be stimulated during various external 
or environmental stresses. Exercise for example, can induce both mitochondrial biogenesis as 
well as mitophagy (67). In this context, the depletion of energy alters the ADP:ATP ratio thereby 
activating AMPK. AMPK has been shown to phosphorylate UNC-51-like kinase 1(ULK1) and 
inhibit mTORC1 contributing to an increase in autophagy and mitophagy specifically (56, 63). 
Exercise has also been shown to increase the expression and activation of transcription factor EB 
(TFEB), the master regulator of lysosomal biogenesis, thus suggesting an increase in capacity for 
autophagy (77). Recently, it has been proposed that PGC-1α and TFEB are coordinated and may 
even regulate each other’s expression and activity (106, 123, 125). This suggests that the two 
dichotomous processes that regulate mitochondrial turnover, mitochondrial biogenesis and 
mitophagy, are highly correlated and coordinated.  
2.0 MITOCHONDRIAL PROTEIN IMPORT 
 
 As previously discussed, mitochondria are not formed de novo, but rather mitochondrial 
proteins are synthesized from both the nuclear and mitochondrial genomes and expand the 
preexisting reticulum. The most recent MitoCarta 2.0 posits that these organelles rely on the 
nuclear genome for 1158 proteins, despite containing their own genomic material (14). Since the 
vast majority of all mitochondrial proteins are transcribed and translated outside of the organelle, 
mitochondria require a sophisticated mechanism of targeting these proteins and allowing their 
		
	 10	
selective passage. Thus, mitochondria rely on their protein import machinery (PIM) to provide 
passage for products of NuGEMPs through the mitochondrial membranes and into their 
designated subcompartments (Fig. 1). All nuclear-encoded proteins contain a mitochondrial 
targeting sequence (MTS) that is recognized by cytosolic chaperones and contains information 
that facilitates their trafficking to the organelle, and their sublocalization within the 
mitochondrion (17). In order to efficiently sort and transport all 1158 nuclear-encoded proteins 
there are several mechanisms for mitochondrial import, which will be outlined in the following 
sections. 
2.1 Canonical Protein Import Pathway 
 The most widely studied pathway for translocation into the mitochondria is through the 
translocases of the outer and inner membrane (TOM and TIM complexes, respectively). 
Translocation through the TOM and TIM complexes is referred to as the canonical import 
pathway since it was the first discovered and is well characterized. However, it really only 
illustrates the mechanism through which proteins enter the mitochondria and localize to the 
matrix and the inner membrane (Fig. 1). Following recognition by cytosolic chaperones such as 
heat shock protein 90 (Hsp90) and 70 (Hsp70), nascent preproteins are unfolded into their 
primary structure to reveal the MTS (27, 130). The TOM complex is widely recognized as the 
general import pore (GIP) and is composed of a β-barrel channel, Tom40, the two primary 
receptors Tom20 and Tom70, and various other regulatory subunits (10). Generally, Tom20 
recognizes MTS found at the N-terminus of nascent proteins in a positively charged α-helix, 
whereas Tom70 has an affinity for preproteins with internally located targeting sequences (11, 
84, 98). Hsp90 is believed to recognize and bind preproteins with internal targeting domains, 
while Hsp70 can bind proteins with or without N-terminal domains, which is regulated by a  
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Figure 1: Mitochondrial protein import machinery. Once a NuGEMP is transcribed and 
translated in the cytosol, it requires a method of entry into the mitochondrion. All products of 
NuGEMPs contain a MTS that is recognized by cytosolic chaperones such as HSP90, to 
facilitate it’s unfolding and direct it to the TOM complex. Various receptor subunits of the TOM 
complex, such as Tom20 and Tom70 bind the preprotein and guide it to the general import pore, 
Tom40. Depending on the transiting protein’s final destination, which is encoded by the MTS, 
small TIM proteins located in the intermembrane space will facilitate their translocation and 
guide them to the appropriate complex. Proteins destined for the outer mitochondrial membrane 
will be guided to the SAM complex, which embeds the protein directly into the outer membrane. 
Similarly, proteins destined for the inner membrane, are guided to Tim22, which embeds the 
protein directly into the membrane, this channel is thought to operate in conjunction with, and 
also independently from the TIM complex. Alternatively, transiting proteins destined for the 
matrix will be guided to the TIM complex. Tim23 is the major channel of this complex and 
allows the passage through the inner membrane. Closely associated with the TIM complex is the 
PAM, whose major component, mtHSP70, binds the transiting protein and actively pulls it into 
the mitochondrial matrix, thus preventing any retrograde movements in the TIM complex. Once 
in the matrix, the MTS is cleaved by MPP, and the nuclear-encoded protein is refolded by 
cytosolic chaperones such as HSP60, into its mature conformation. Mitochondria also contain 
their own genomic material, which encodes 13 components of the electron transport chain. These 
genes are transcribed and then translated in the matrix and then embedded in the inner membrane 
and assembled into mature holoenzymes through Oxa1. (Adapted from 38, 85). 
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series of co-chaperones (43, 121). Hsp70 and Hsp90, have been shown to bind the Tom70 
receptor, thereby initiating protein translocation (27, 130). 
 The receptor subunits then pass on the transiting protein to Tom22, and eventually 
Tom40, however the mechanism for this interaction is dependent on the receptor (10). 
Preproteins recognized by Tom20 are passed on to Tom22 through a series of binding events 
known as the “binding chain hypothesis” (17). In this model, Tom6 and Tom7 play reciprocal 
roles in stabilizing and destabilizing the interaction between receptor and pore, respectively (26, 
42). Alternatively, proteins recognized by the Tom70 receptor are transferred in a manner known 
as the “translocation in loop formation” where the C- and N-termini are both exposed to the 
cytosol and the middle section is exposed to the IMS first (26). Both mechanisms rely on 
membrane potential (ΔΨ) for translocation through the outer membrane (11). The TOM complex 
acts as a common gate for all nuclear encoded proteins, from which they are further sorted based 
on their final destination within the mitochondria.  
Proteins destined for the mitochondrial matrix are guided from Tom40 through the IMS 
by small TIM proteins (114). The TIM complex has a similar organization as the TOM complex. 
It contains a general pore (Tim23) through which proteins in a linear conformation are able to 
pass, a receptor (Tim44), and various regulatory subunits (22). Small TIM chaperones in the IMS 
guide translocating proteins to Tim44. Passage through Tim23 channel is mediated in part by the 
magnitude of ΔΨ and the availability of ATP (38, 115). Following activation or recognition of a 
preprotein, Tim44 dimerizes on the matrix domain of the complex to recruit mtHSP70, a 
mitochondrial chaperone, to assemble the presequence translocase-associated motor (PAM) (7, 
18). Through the utilization of ATP, mtHSP70 acts as a ratchet to pull preproteins through the 
channel and prevent retrograde movements into the IMS (51). This is a critical step since Tim23 
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does not bind translocating proteins tightly and can therefore oscillate when moving through the 
channel (7). Once inside the mitochondrial matrix, the N-terminus MTS is cleaved off by 
mitochondrial processing peptidase (MPP) and refolded by various mitochondrial chaperones 
such as cpn10, into their mature conformation (33).  
Translocation through the TIM complex requires not only ΔΨ, but also the availability of 
ATP (115). To ensure that these requirements are met, the TIM complex has been shown to 
associate with complex IV and complex III of the ETC (38). It is thought that this interaction 
ensures that the ΔΨ is maintained in proximity to the channel and also certifies the supply of 
ATP. Thus the import pathway, though costly and complicated, has evolved in a manner to 
promote its efficiency. 
2.2 Non-Canonical Import Pathways 
 As described, the TIM complex is mainly responsible for the trafficking of matrix and 
inner membrane destined proteins, however there are other channels that facilitate the 
translocation into other subcompartments within the organelle. In this model, the TOM complex 
acts as a general pore for all nuclear-encoded mitochondrial proteins allowing their transport 
through the outer mitochondrial membrane (26, 84). From this point, preproteins are targeted to 
different channels based on their MTS, which contains information about their sublocalization 
within the organelle. In the following sections, two other methods of protein import will be 
discussed (Fig. 1).  
2.2.1 Sorting and Assembly Machinery (SAM) Complex 
 The sorting and assembly machinery (SAM) complex is a main constituent of the β-barrel 
pathway, known for mediating the insertion of nuclear-encoded proteins destined for the 
mitochondrial outer membrane (10). The SAM complex is integral for the biogenesis and 
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assembly of the TOM complex because of its role in mediating the insertion of Tom40 (6). It is 
comprised of two essential subunits, Sam50 and Sam35, which contribute to channel formation 
(82). Preproteins destined for the mitochondrial outer membrane contain a β-signal that is 
recognized by Sam35 and initiates the opening of Sam50 channel (62). Concurrent with this 
recognition, the cytosolic domain of Tom22 physically interacts with the cytosolic domain of a 
regulatory subunit, Sam37, forming a TOM-SAM supercomplex (114). This interaction 
facilitates the transition of the preprotein from the TOM complex to the SAM complex by 
bringing the transiting preprotein and small TIM chaperones in close proximity to the SAM 
complex (114).  Following translocation through the SAM complex, the mitochondrial 
distribution and morphology (MDM) complex facilitates the insertion and assembly of β-barrel 
proteins into the outer membrane (11).  
2.2.2 Translocase of the Inner Membrane 22 (Tim22) 
 Similar to the proteins destined for the outer mitochondrial membrane, there exists a 
distinct pathway for the insertion of carrier proteins destined for the inner membrane. The 
translocase of the inner membrane 22 (Tim22) is a voltage-gated channel that responds to 
internal targeting sequences of multitopic proteins destined for the inner membrane (51, 60, 88). 
Passage through this channel does not require ATP or mtHSP70, but rather, transport is driven 
primarily by membrane potential (81). In this pathway, preproteins are recognized by Tom70 and 
translocate through Tom40 into the IMS through the “translocation in loop formation” 
hypothesis. Within the IMS small TIM chaperones, Tim9 and Tim10, associate with the three 
positive matrix-facing loop modules found in carrier proteins destined for the inner membrane 
and guide the protein to Tim22 (51). Tim10 then interacts with a subunit of the TIM22 complex, 
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Tim12, facilitating the docking of the preprotein to the channel and allowing its voltage-
dependent movement into the inner membrane (7).  
 Tim22 is integral for the translocation and insertion of carrier proteins into the inner 
membrane, and has also been shown to mediate the insertion of Tim23 and Tim17 (96, 111). 
However, there do exist other pathways that mediate the integration of nuclear-encoded proteins 
into the inner membrane (51). The first is the conservative sorting pathway, in which proteins are 
imported into the mitochondrial matrix through the TIM complex, and then inserted into the 
membrane through the matrix side via mitochondrial oxidase assembly protein 1 (Oxa1), an 
export channel (17, 38, 61). The second is the stop-transfer pathway where the hydrophobic 
region of the transmembrane region arrests its translocation to the matrix and directs its 
movement laterally into the inner membrane (17, 38). Therefore, there could be some 
redundancy within the import pathway to ensure efficiency and stoichiometric maintenance.  
2.3 Plasticity of Protein Import 
 Protein import was widely thought to be a static process, and its dynamic ability to sense 
and respond to the cell’s environment and metabolic status went overlooked for quite some time. 
Evidence predominantly in yeast, and more recently in mammals, has demonstrated that 
mitochondrial protein import is a regulatory hub for modulating metabolism as well as various 
stress responses (38). Thus, the following sections will describe how protein import can adapt to 
environmental stimuli and its role as a mitochondrial status sensor in mediating stress responses.  
2.3.1 Differences in Mitochondrial Subfractions 
 As previously discussed, mitochondrial exist in two related yet functionally and 
biochemically distinct subfractions within skeletal muscle: subsarcolemmal (SS) and 
intermyofibrillar (IMF). Based on their subcellular localization, these pools are equipped to 
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support different subcellular processes. For example IMF are primarly responsible for supplying 
ATP for actin-myosin crossbridge cycling. A study conducted by Takahashi and Hood, 
demonstrated that IMF mitochondria have a 3-4 fold higher rate of import into the mitochondrial 
matrix and that this is surprisingly not related to ATP production rate (117). They also 
demonstrated that SS have a greater reliance on cardiolipin, a phospholipid present only in the 
mitochondrial membrane for protein import, therefore the mechanism and capacity for protein 
import differ in mitochondrial subfractions within skeletal muscle (117). Thus it is proposed that, 
in part, mitochondria in part derive a portion of their compositional and functional heterogeneity 
between pools based on differential regulation of the protein import pathway.  
2.3.2 Adaptability of the PIM 
 The ability for the mitochondrial reticulum to adapt and respond to various environmental 
stimuli is what makes it such a dynamic and metabolically relevant organelle. Protein import 
plays a large role in mediating the adaptability of the organelle since it mediates the expansion of 
the reticulum. It is widely known that repeated bouts of endurance exercise result in increased 
mitochondrial content, and many studies have focused on various transcription factors and 
coactivators that coordinate changes to gene expression to promote this adaptation. However, 
chronic contractile activity has also been shown to increase the expression of various PIM 
components and the assembly of the import complexes, thereby increasing the capacity for 
protein import and thus, mitochondrial expansion (53, 116). Besides the elevation in PIM 
content, exercise may also influence the rate of protein import following exercise. Takahashi et 
al. demonstrated that the addition of a cytosolic fraction from an animal subjected to a model of 
endurance exercise stimulates the rate of protein import in mitochondria isolated from control 
animals by 2-fold (116). These findings identified that the increased import rate was in part due 
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to increased mitochondrial import stimulating factor (MSF) present in the cytosolic fraction of 
trained animals. However, MSF is not the only factor required for this acceleration, but these 
stimulants remain to be identified (116). Therefore, the ability of PIM to respond to increased 
metabolic demand contributes to mitochondrial biogenesis in the context of exercise training.  
 Conversely, there are various instances that depress protein import in the face of cellular 
stress. Muscle atrophy as a result of muscle disuse has garnered a lot of attention, especially the 
mechanisms that underlie this muscle wasting and the concomitant mitochondrial dysfunction. 
Typically, the stars of muscle atrophy are proteolytic pathways that are increased and promote an 
exaggerated rate of protein breakdown leading to this phenotype. However, using a denervation 
model, Singh et al. highlighted a role for protein import in mediating and exacerbating muscle 
atrophy. In this model, chronic muscle disuse increases reactive oxygen species (ROS) 
production, which negatively influences the rate of protein import in a dose-dependent manner 
(110). The reduction in protein import exacerbates the decline in mitochondrial content thereby 
serving as a positive feedback loop promoting proteolytic pathways and aggravating muscle 
atrophy (110). The sensitivity of the protein import pathway to ROS suggests a potential 
mechanism for mitochondrial dysfunction and reduced content in the face of oxidative stress, 
which has yet to be further explored.  
2.4 Role of Import in Metabolism 
As outlined in the previous sections, import is a crucial step in the regulation of 
mitochondrial biogenesis and the maintenance of organelle content during health and disease 
states. Besides its role in mediating the expansion of the reticulum, import is also vastly 
intertwined in metabolism and the overall maintenance of the mitochondrion.  
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 Import has widely been studied in yeast, and work from these lower order organisms has 
outlined a role for protein import during respiration and fermentation based on the availability of 
glucose.  In yeast, protein kinase A (PKA) is inactive in the absence of glucose, allowing import 
to proceed and to promote respiration. However, when glucose is in high abundance, PKA is 
activated and phosphorylates Tom40 thereby negatively impacting protein import and limiting 
mitochondrial biogenesis (38, 85). PKA has also been shown to target the receptor Tom70 to 
impair the binding of cytosolic chaperones to initiate translocation (38). Work in yeast has 
highlighted the transient post-translational level of regulation on the PIM, through 
phosphorylation events that can impact import rate and assembly.  
 Recently, the understanding of protein import has undergone a paradigm shift where 
import is now being appreciated for being more than a mere means of entry into the organelle, 
but also a sensor of mitochondrial status and for communicating this with the cell. An example 
of this is the PINK1/Parkin-dependent pathway of mitophagy. PINK1 is a kinase with a 
mitochondrial matrix targeting sequence, which under basal conditions is imported into the 
mitochondrial matrix and degraded by a mitochondrial protease, presenilins-associated 
rhomboid-like protein (PARL) (95, 127). However, since protein import into the matrix is 
dependent on ΔΨ, when the organelle is dysfunctional, a hallmark characteristic is a loss of 
membrane potential. PINK1 is no longer imported into the matrix and its translocation is arrested 
at the outer membrane where it can recruit Parkin, an E3 ubiquitin ligase, from the cytosol (78). 
Parkin ubiquitinates outer membrane proteins that flag the organelle for degradation through 
mitophagy (23). Thus the inability for the organelle to import selective proteins can initiate 
mitochondrial recycling processes to maintain an optimal pool. Therefore, this illustrates that 
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protein import is in a unique position to rapidly detect changes in potential as a marker for 
mitochondrial status and communicate this loss of function with the cell (38, 59). 
 Similarly, in lower order organisms, a role for import in the early signaling events of a 
protein quality control has recently been discovered. The mitochondrial unfolded protein 
response (UPRmt) will be discussed in a later section, but briefly it is responsible for removing 
proteotoxic stress within the mitochondria by either refolding or degrading misfolded proteins 
(54). In C. elegans, activating transcription factor associated with stress-1 (ATFS-1) is normally 
imported into the mitochondrial matrix and degraded by LonP. However, when the UPRmt is 
activated, ATFS-1 import into the mitochondrion is blocked and it preferentially translocates into 
the nucleus. The mechanism for this switch is still poorly understood but is described in detail 
elsewhere (80). This quality control mechanism is just another example of how protein import 
serves as a sensor of mitochondrial fitness in an attempt to regain homeostasis. Therefore, import 
is not merely a means of entry into the organelle, but rather has far-reaching implications in 
metabolism and cellular homeostasis.  
3.0 MITOCHONDRIAL PROTEOSTASIS 
 Protein conformation dictates structure and function, and for this reason protein folding is 
a crucial step in protein maturation. Unfortunately, protein folding is an inherently error-prone 
process and misfolded proteins can be toxic to the cell if left to accumulate. Therefore, protein 
homeostasis, commonly referred to as “proteostasis” must be maintained by either refolding or 
degrading misfolded proteins (40). Within the cell, there are various organelles that are more 
prone to protein misfolding due to their function or structure, such as the endoplasmic reticulum 
(ER) and the mitochondria. The ER is where a large proportion of proteins are translated and 
assume their mature conformation; therefore it is equipped with its own unfolded protein 
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response (UPRER) (126). As previously discussed, due to the nature of protein import pathway, 
mitochondrial proteins must be unfolded in order to pass through the β-barrel channels of the 
outer and inner membrane, and then be refolded upon reaching their destination. Thus protein 
folding takes place within the various subcompartments of the organelle, making mitochondria 
susceptible to misfolding. It is therefore equipped with an independent unfolded protein response 
(UPRmt) (54).  
3.1 Mitochondrial UPR in C. elegans 
 The UPRmt is a highly conserved quality control mechanism that was first discovered in 
mammals, but has since been well characterized in C.elegans (3, 47, 89). Similar to mammals, 
the UPRmt aims to regain proteostasis by refolding or degrading misfolded proteins that may 
exert toxic effects on the organelle (Fig. 2). Within the mitochondria, the IMS and matrix are 
both major sites for protein misfolding and are thus equipped with compartment-specific 
chaperones and proteases to remove proteotoxicity (54). If ever this stress exceeds the capacity 
of the subcompartment to deal with it, the UPRmt initiates retrograde signaling cascades to 
increase the expression of protein quality control (PQC) genes (76) (Fig. 2).   
 In these lower order organisms, misfolded proteins can be degraded by caseinolytic 
mitochondrial matrix peptidase (ClpP) into 6-30 amino acid protein fragments, which have been 
shown to be important in the retrograde signaling events (39, 58). These proteolytically-derived 
peptides are exported from the matrix through a channel in the inner membrane, HAF-1, and are 
thought to readily diffuse through the outer membrane into the cytosol (41). The presence of 
these protein fragments in the cytosol influences the tranlocation of activating transcription 
factor with stress-1 (ATFS-1) (40, 80). ATFS-1 contains both a nuclear localization signal (NLS) 
and a MTS, allowing for its dynamic regulation (80). Basally, ATFS-1 is imported into the  
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Figure 2: Mitochondrial unfolded protein response in C. elegans. Basally, ATFS-1, the 
homologue of ATF5, is imported into the mitochondrion and degraded by LonP. However, in the 
presence of proteotoxic stress, Clpp-1 degrades misfolded proteins into peptides. These peptides 
are then exported into the cytosol by HAF-1. Once in the cytosol, these peptides block the ability 
of ATFS-1 to translocate into the mitochondrion and therefore force its movement into the 
nucleus. The mechanism for this is still unknown. The accumulation of misfolded proteins also 
activates DVE-1 and Ubl5, two transcription factors that heterodimerize upon entry into the 
nucleus. Together, DVE-1, Ubl5 and ATFS-1 promote the transcription of mitochondrial 
chaperones, proteases and import components, thereby increasing the organelle’s capacity to deal 
with future proteotoxic insults. (Adapted from 54, 89). 
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mitochondrial matrix and degraded by LonP, however in the presense of these peptides, ATFS-1 
preferentially localizes to the nucleus where it increases the expression of a host of genes to 
regain proteostasis (55, 80). ATFS-1 is responsible for transcriptionally upregulating 
mitochondrial chaperones, proteases, import components, detoxification enzymes and autophagy 
markers as a means of increasing the capacity to deal with future stress (89). However, ATFS-1 
is not the only transcriptional regulator activated during the UPRmt. DVE-1 and Ubl5 also 
translocate into the nucleus to upregulate various chaperones and proteases, some of which are 
also targets of ATFS-1 thereby providing some redundancy in the system (55). 
 Work in C.elegans has also demonstrated that the UPRmt has other functions besides the 
maintenance of proteostasis. Activation of the UPRmt has been documented to play a role in 
metabolism, innate immunity, longevity and the metabolic coordination of distal tissues (9, 66, 
73, 79, 90, 118). It was originally thought that under stress conditions ATFS-1 was completely 
redirected into the nucleus, however it has become clear that a portion of total ATFS-1 is still 
imported into the mitochondria during stress and can bind to the UPRmt element (UPRmtE) within 
mtDNA. This redistribution of ATFS-1 limits the accumulation of both nuclear- and 
mitochondrial-encoded oxidative phosphorylation transcripts, while simultaneously promoting a 
shift towards glycolysis. Many of the OXPHOS genes do not contain UPRmtE in their promoters, 
therefore it is thought that this repression may be indirect.  This provides an important switch 
during stress towards a greater glycolytic reliance, thereby providing the organelle with time to 
repair.  
In lower-order organisms activation of the UPRmt has been found to display mitohormetic 
effects. Mitohormesis is a process through which low levels of mitochondrial stress are actually 
beneficial in promoting increased lifespan and protection against future insults (131). Recently 
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various papers have begun to describe how the activation of the UPRmt also promotes chromatin 
remodeling through the upregulation of histone lysine demethylases, histone methyltransferases 
and nuclear co-factors (73, 118). These epigenetic modifications promote longevity when 
activated through the UPRmt as a result of mild mitochondrial stress. It is thought that activation 
of the histone methyltransferase, met2 and lin-65, a nuclear co-factor, reorganize the chromatin 
to allow DVE-1 DNA binding. This also promotes persistant reorganization of the chromatin, 
thereby extending lifespan (118). 
This quality control mechanism has garnered attention in neural tissue since its activation 
is frequently seen in neurodegenerative diseases. Work in neurons of C.elegans in 2016 
uncovered an endocrine-like function of the UPRmt. In this model, activation of the UPRmt in 
neurons promotes the release of serotonin, which communicates with distal tissues to activate the 
UPR and coordinate metabolism, despite no proteotoxic stress in these tissues (9). At around the 
same time, another group discovered a neuropeptide, FLP-2 that is released from neurons 
undergoing proteotoxicity and coordinates non-autonomous activation of the UPRmt and 
metabolism (108). This is intriguing because many neurodegenerative diseases display declines 
in metabolism in tissues outside of the central nervous system. However, it is unclear if the 
release of serotonin and FLP-2 is coordinated or if they are independent, and whether or not 
these are viable targets for treatment in mammals.  
3.2 Mitochondrial UPR in Mammals 
  The mammalian UPR is a highly conserved quality control mechanism that shares many 
parallels with c.elegans, however it is not as well characterized as in invertebrates. Similar to 
c.elegans, the UPRmt is subcompartment specific, and as such it is equipped with chaperones and 
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proteases specific to either the IMS or the matrix, and stress within each compartment results in 
activation of compartment specific transcriptional programs (55).  
 Protein misfolding can occur in any of the subcompartments within the mitochondria due 
to the nature of the PIM and the organelle’s reliance on both genomes (54). When proteins 
accumulate in the IMS, there are a host of compartment-specific proteases, such as OMI, in place 
to proteolytically relieve the stress. Proteotoxic stress within the IMS induces an increase in 
ROS, which culminates in the activation of estrogen-related receptor-α (ERRα) through its 
phosphorylation by Akt (76). ERRα can act as a transcription factor upon activation to increase 
an IMS-specific transcriptional program.  
 Alternatively, proteins that become unfolded or are not incorporated into their 
holoenzyme (i.e. orphaned subunits) within the matrix activate a different branch of the UPRmt 
(Fig. 3). Proteotoxicity within the matrix is handled by a variety of chaperones such as Hsp60, 
and chaperonin 10 (cpn10) and resident proteases such as ClpP, and LonP (55). Perturbation of 
matrix-specific proteostasis prevents further accumulation by degrading Tim17, a regulatory 
subunit of the TIM complex, by membrane bound protease Yme1l to reduce protein import into 
the compartment. Concurrently, dsRNA-activated protein kinase (PKR) phosphorylates eIF2α to 
inhibit global protein translation similar to the integrated stress response (ISR) (86). 
Furthermore, JNK2 senses the increased ROS production typically seen with proteotoxic stress, 
which in turn activates c-jun, a transcription factor that regulates CHOP (3). CHOP 
heterodimerizes with C/EBPβ to upregulate mitochondrial UPR genes and increase the capacity 
of the organelle to deal with future proteotoxic stress (76, 133). Interestingly, CHOP is also a 
regulator of the UPRER, however the genes that are transcriptionally upregulated are different 
depending on which compartment the stress originated in (126). The mitochondrial PQC genes  
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Figure 3: Mammalian mitochondrial unfolded protein response. Under conditions of stress 
or high volumes of protein synthesis, proteins may become misfolded. In order to combat the 
toxic effects that are exerted by misfolded proteins, the mitochondrion is equipped with a protein 
quality control mechanism termed the UPRmt. Misfolded proteins can either be refolded into a 
mature conformation by resident chaperones, such as cpn10 and HSP60, or degraded by 
proteases, such as LonP and ClpP. If the stress exceeds the capacity of these quality control 
proteins, misfolded proteins can accumulate and aggregate. This accumulation is typically 
associated with an elevation of ROS, which signals the activation of the UPRmt. In response, 
PKR is activated and phosphorylates eIF2α, which inhibits global translation, while promoting 
the translation of transcripts that contain uORFs. In order to combat the elevation in ROS, a 
deacetylase, SirT3 is activated to promote the transcription of mitochondrial antioxidants. 
However, if the stress is prolonged and unresolved, SirT3 can also promote the recycling of the 
organelle through mitophagy. JNK, a mitogen-activated protein kinase, can sense the heightened 
ROS and promote the transcription of CHOP and C/EBPβ, through the phosphorylation of 
transcription factor c-jun. CHOP and C/EBPβ then heterodimerize to transcriptionally upregulate 
various mitochondrial chaperones and proteases. ATF5’s activation is thought to be dependent 
on the export of proteolytically-derived peptides, thus promoting its translocation into the 
nucleus where it acts as a transcription factor to promote the transcription of LonP, HSP60 and 
mtHSP70. Both ATF5 and CHOP increase the capacity to deal with future mitochondrial 
proteotoxic stress.  (Adapted from 54, 76). 
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regulated by CHOP all contain a UPRmt response elements (MURE) that flank the CHOP 
binding site within the promoters of its target genes (3). These MURE sites may provide a level 
of specificity during CHOP activation, however no transcription factors or co-factors to date 
have been found to bind these elements.  
  Concurrent with the activation of CHOP, ROS is also responsible for activating another 
independent branch of the UPRmt. SirT3, a deacetylase sensitive to the increased oxidative stress 
typically seen with proteotoxicity, activates forkhead box O3 (FOXO3) promoting its nuclear 
translocation (87). FOXO3 transcriptionally regulates antioxidant proteins and the activation of 
mitophagy, thereby increasing antioxidant machinery to combat the elevated ROS. During 
prolonged exposure to proteotoxicity, mitophagy is able to recycle the damaged organelle 
through the PINK1-Parkin pathway, if the stress is not dealt with. Interestingly, this recycling 
does not require the canonical loss of membrane potential, but rather seems to be initiated due to 
competitive proteolytic degradation whereby PINK1 can no longer be degraded because the 
mitochondrial proteases are targeting the misfolded proteins (52).  
 Despite the evolutionary conservation of the UPRmt throughout many species, there are 
however some differences between invertebrates and mammals. Roles for the mammalian 
homologues of DVE-1 and Ubl5, SatB2 and Ubl5 respectively, in regulating changes in gene 
expression have not been identified to date. Furthermore, until recently it was unclear whether or 
not proteolysis had similar signaling roles in mammals as it does in c.elegans. As previously 
described, in worms the proteolytic byproducts are exported from the matrix into the cytosol 
where they influence the translocation of ATFS-1 (58, 80). Less than a year ago, ATF5 was 
identified as the mammalian homologue of ATFS-1, and preliminary evidence suggests that it is 
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regulated in a similar fashion to its nematode counterparts (31). The exact mechanism of this 
retrograde signaling has yet to be investigated.  
 The novel roles for the UPRmt in mediating longevity, coordinating metabolism and non-
autonomous regulation of distal tissues in invertebrates, has warranted the question of whether or 
not these are paralleled in mammals. Unfortunately, activation of the UPRmt and extension of 
lifespan do not seem to be related phenomena in mammals. This could be due to the complexity 
of mammals compared to lower-order organisms like Caenorabditis elegans and Drosophila 
melanogaster. However activation of quality control mechanisms in mammalian skeletal muscle 
was shown to promote the release of a myomitokine, GDF15 (19). This growth and 
differentiation factor then acts in an endocrine fashion to regulate metabolism in distal tissues to 
protect against obesity and insulin resistance (19). Therefore, although the UPR is a highly 
conserved mechanism, there are some major differences between species.  
3.3 Retrograde Signals in the UPR 
 Communication between the mitochondrion and the nucleus is mediated by a plethora of 
signaling molecules. The aim of the UPR is to regain proteostasis in the face of accumulated 
misfolded proteins, and to protect the organelle from future stress. The latter is achieved through 
changes in gene expression that drive the synthesis of new chaperones and proteases, thus 
increasing the capacity to deal with future insults. This communication during the UPRmt is 
thought to be mediated by two retrograde signaling molecules: ROS and proteolytic byproducts, 
or peptides.  
3.3.1 Reactive Oxygen Species (ROS) 
 Reactive oxygen species are radical molecules notorious for inducing DNA damage and 
oxidizing proteins, thereby altering their function by modifying critical amino acid residues. On 
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the other hand, ROS are indispensible to the cell for its role as a signaling molecule and for 
mediating adaptations, such as exercise-induced mitochondrial biogenesis (100). Thus, ROS 
exhibit a mitohormetic effect, whereby up to a theoretical threshold ROS are beneficial to the 
cell but past this limit they are detrimental due to their role in damaging redox reactions. 
Mitochondria are a large site for ROS production within the cell. This occurs when electrons 
prematurely slip from complex I or III leading to the early reduction of oxygen and the 
generation of superoxides.  
 Oxidative stress is tightly coupled to protein folding, since the presence of ROS may 
induce protein misfolding, and proteotoxic stress may itself increase ROS production. Thus, 
ROS are pivotal signaling molecules during the UPRmt, and they mediate, in part, the 
communication between the mitochondrion and nucleus in this response (89). Within the 
organelle ROS are sensed by JNK, a mitogen sensitive kinase that phosphorylates c-jun, a 
transcription factor, resulting in an increase in CHOP and C/EBPβ expression (76). The exact 
mechanism through which ROS activate JNK is still poorly understood, but it is thought that they 
modify upstream regulators of JNK (113). For example, ASK1 is a regulator of JNK basally, 
held inactive through its interaction with thioredoxin. However in the presence of oxidative 
stress, thioredoxin is oxidized and released from ASK1, thereby activating JNK (112).  ROS 
have also been shown to directly inhibit MKPs, which maintain the JNK pathway in an inactive 
state (112). In the context of the UPRmt signaling, the mechanism for ROS sensing has not been 
studied.  
 Alongside this, SirT3 is activated in a ROS-dependent manner to induce antioxidant 
machinery and mitophagy, if necessary. The mechanism through which ROS mediate the 
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activation of SirT3 is still unclear, however using ROS scavengers such as NAC, ROS have been 
shown to be critical in the activation of SirT3 in the context of UPRmt (87). 
3.3.2 Mitochondrial Proteolysis 
 During the UPRmt, misfolded proteins are degraded into protein fragments (i.e. peptides) 
by resident proteases. From a series of experiments conducted in C.elegans, a role for peptides in 
mediating retrograde signaling during the UPRmt was elucidated. In this model, ablation of ClpP, 
a mitochondrial protease decreased the production of these peptides and reduced the activation of 
ATFS-1 (39). In mammals, the role of ClpP in mediating UPRmt signaling remains highly 
controversial in the literature. Work in muscle cells using knockdown of ClpP and the 
overexpression of its chaperone subunit, ClpX, provide evidence for its role in the UPRmt (2, 21). 
However, in cardiac muscle in a model of cardiomyopathy, loss of ClpP does not affect the 
UPRmt (107). In C. elegans, knockdown of HAF-1, the channel through which peptides are 
emitted from the matrix, reduces the ability of the cell to combat proteotoxic stress (41). It is 
proposed that the proteolytic byproducts are released into the cytosol where they promote the 
nuclear translocation of ATFS-1 into the nucleus, allowing it to transcriptionally activate PQC 
genes (58, 80).  Although, the mammalian homologue of HAF-1, ABCB10 does not appear to 
facilitate the export of peptides from the mitochondrion, it may however have a role in UPRmt 
signaling though the mechanism is still unknown (129). 
 The mechanism for this retrograde signal has not been elucidated, however there are 
some proposed theories that have yet to be experimentally tested (58). The first hypothesis is that 
the peptides are acting directly on a cytosolic peptide receptor that then influences ATFS-1 
translocation. Another possibility is that the peptides themselves are not being sensed, but rather 
the rate at which peptides are exported into the cytosol is a signal for ATFS-1 nuclear 
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translocation. The third hypothesis is that the presence of peptides in the cytosol influences the 
PIM to inhibit the translocation of nuclear proteins into the mitochondria. This therefore redirects 
ATFS-1 translocation from the mitochondrion to the nucleus.  
 Thus based on the current understanding of the mammalian UPRmt and its activation, we 
aim to elucidate its relationship with protein import in the stoichiometric maintenance of the 
mitochondrion. By perturbing the import machinery in vivo we can address the effects of a mito-
nuclear imbalance on mitochondrial function and proteostasis within skeletal muscle. 
Furthermore, we wish to address the mechanisms that mediate the communication between the 
mitochondrion and the nucleus during UPRmt activation. The retrograde signals involved in this 
process have yet to be elucidated. Understanding the signaling events involved in the UPRmt will 
promote better understanding of the maintenance of proteostasis since it has been implicated in 
aging, neurodegenerative disorders and various cancers.  
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RESEARCH OBJECTIVES  
Thus, based on my review of literature, the objectives of my thesis were to: 
1. Study the relationship between an import defect and the maintenance of stoichiometry 
between the nuclear and mitochondrial genomes; 
2. Examine the effect of a mito-nuclear protein imbalance in vivo on mitochondrial function 
in skeletal muscle by perturbing the PIM, specifically Tim23; 
3. Explore mitochondrial proteolysis and the release of peptides in a mammalian model; 
4. Investigate a potential role for peptides in retrograde signaling by mediating protein 
import during UPRmt activation. 
HYPOTHESES 
1. A mitochondrial protein import defect will perturb the balance between the nuclear and 
mitochondrial genomes thereby activating the UPRmt to maintain proteostasis; 
2. Partial loss of Tim23 will result in mitochondrial dysfunction, characterized by a deficit 
in protein import, reduced respiratory capacity and elevated ROS emission; 
3. Mitochondria will release protein fragments, and this proteolysis and subsequent export 
will be susceptible to oxidative stress; 
4. Mitochondrially-derived peptides will negatively influence protein import in a dose- and 
time-dependent manner, thereby serving as a possible mechanism for communicating a 
loss of proteostasis within the mitochondrion to the nucleus to modify gene expression. 
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ABSTRACT 
 The mitochondrial unfolded protein response (UPRmt) is a compartment-specific protein 
quality control mechanism that strives to achieve proteostasis in the face of misfolded or 
misassembled proteins. Due to the mitochondrion’s reliance on both the nuclear and 
mitochondrial genomes, a perturbation of the coordination of these genomes results in a mito-
nuclear imbalance in which holoenzymes are unable to assume their mature stoichiometry and 
thereby activates the UPRmt. Thus, we sought to perturb this genomic coordination by using a 
systemic anti-sense oligonucleotide (in-vivo Morpholino) targeted to Tim23, the major channel 
of the inner membrane. This resulted in a 40% reduction in Tim23 protein content, and a 
corresponding 60% reduction in protein import into the matrix, but not to other 
subcompartments. This matrix-specific import defect was sufficient to activate the CHOP-branch 
of the UPRmt, as evident from increases in ClpP and cpn10, but not the ATF5 arm. This 
demonstrated that, in the face of proteotoxic stress, CHOP and ATF5 could be activated 
independently to regain proteostasis. Our second aim was to investigate the role of 
proteolytically-derived peptides in mediating retrograde signaling. To do so, peptides released 
from the mitochondrion following basal proteolysis were isolated and incubated with import 
reactions. A dose- and time-dependent effect of peptides on protein import was observed. Our 
data suggest that mitochondrial proteolytic byproducts exert an inhibitory effect on the protein 
import pathway, possibly to reduce excessive protein import as a potential negative feedback 
mechanism. The inhibition of import into the organelle may also serve as a retrograde function, 
to modify nuclear gene expression and ultimately improve organelle folding capacity.  
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INTRODUCTION 
Proteostasis refers to the maintenance of proper protein synthesis, maturation and 
degradation to ensure a functional proteome (1, 2). Proteins that are unable to assume their 
tertiary or quaternary structures exert toxic effects on the cell, referred to as proteotoxicity (29, 
34). Within the mitochondrion, the goal of achieving protein homeostasis is complex since it is 
the only organelle that contains its own genome, and therefore generates its own gene products. 
There, the maintenance of a functional stoichiometry relies on the coordination of both nuclear 
and mitochondrial genomes, as well as proper protein handling and maturation (5).  
Despite containing their own genetic material, mitochondria rely heavily on the nuclear 
genome for over 99% of all mitochondrial proteins, while mtDNA encodes for 13 proteins that 
are transcribed and translated within the organelle (7). Furthermore, due to the double-membrane 
structure of the mitochondrion, products of nuclear genes encoding mitochondrial proteins 
(NuGEMPs) require a sophisticated mechanism for mediating their sorting and translocation. 
Mitochondrial protein import is a complex mechanism through which proteins are recognized via 
their mitochondrial targeting sequence (MTS) by cytosolic chaperones and delivered to the 
protein import machinery (PIM) within the organelle (6, 8). Products of NuGEMPs are 
recognized by cytosolic chaperones that guide proteins to the translocases of the outer 
membrane, the TOM complex. These chaperones are also responsible for unfolding their cargo 
into a linear structure to faciliate their passage through the β-barrel channel of the TOM 
complex, and subsequently through the translocase of the inner membrane, the TIM complex (4). 
Once in its final destination, such as in the matrix, the MTS is cleaved by mitochondrial 
processing peptidase (MPP) the protein is refolded by mitochondrial chaperones to assume its 
mature conformation (18). Many of these nuclear products can then combine with 
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mitochondrially-encoded subunits to form mature holoenzymes. Previous research has shown 
that protein import is a dynamic process that can respond to the metabolic status of the cell, 
thereby promoting the balance between the nuclear and mitochondrial genomes (9, 14). 
However, this process is laden with potential points for protein misfolding or misassembly, 
which may exert proteotoxic stress on the organelle.  
To combat proteotoxicity, mitochondria are equipped with a protein quality control 
mechanism, the unfolded protein response (UPRmt). The UPRmt is a compartment-specific 
response that detects misfolded proteins and either refolds them through the use of chaperones 
(cpn10, Hsp60), or degrades them via proteases (LonP, ClpP) to eliminate the proteotoxic stress 
that they exert on the organelle (26). When the stress exceeds the capacity of resident quality 
control proteins, a retrograde signal is initiated through various mechanisms including an 
increase in reactive oxygen species (ROS) to indirectly activate CHOP and C/EBPβ, which 
transcriptionally regulate various mitochondrial chaperones and proteases (19). ATF5, a recently 
discovered transcription factor, is also activated, however the mechanism involved in this 
activation are currently unknown in mammalian cells (12). Work in C. elegans originally led to a 
proposed role for proteolytically-derived peptides in mediating the nuclear translocation of 
ATF5. In these organisms, the byproducts of proteolysis within the mitochondrion are released 
into the cytosol, and this is required for the activation and nuclear translocation of the homologue 
of ATF5, ATFS-1, where it can promote a compensatory gene expression response (15, 16, 27). 
Based on this research, the UPRmt appears to be designed to selectively promote the transcription 
of protein quality control genes, while transiently arresting other sources of proteotoxic stress 
(11).  
 However, since its discovery in 2002, our understanding of the UPRmt is primarily 
			
		 47	
derived from work in lower order organisms, and our knowledge regarding its mammalian 
counterpart is still lacking (2, 26). Therefore, the first purpose of this study was to investigate the 
consequence of UPRmt induction in skeletal muscle by inducing a mito-nuclear imbalance. This 
was achieved by knocking down Tim23, the major channel of the TIM complex with an 
injectable anti-sense oligonucleotide. Our second purpose was to investigate the effect of 
peptides on the import process, and their potential role as a retrograde signal. We expected that 
mitochondrially-derived peptides would negatively influence import in a dose- and time-
dependent manner.  
METHODS 
Animal Care and In-Vivo Morpholino Treatment- C57BL/6 mice (3 months) were housed in the 
vivarium and given food and water ad libitum under a 12hr light/dark cycle. In-Vivo 
Morpholinos (GeneTools, OR, USA) were designed to target Tim23 and were dissolved in 
phosphate-buffered saline at a concentration of 5mM as recommended by the manufacturer. 
Animals were administered a dose of 12mg/kg per day via intraperitoneal injection for three 
consecutive days (10). Control animals were treated with a standard control oligo offered 
through GeneTools at the same dose. Mice were sacrificed 48hr following their last injection by 
cervical dislocation and tissues were promptly harvested. Tibialis anterior, extensor digitorum 
longus, quadriceps, and triceps were collected from both hindlimbs and used immediately for 
mitochondrial isolations. Gastrocnemius muscles, heart and liver were frozen in liquid nitrogen 
and stored at -80°C for later analysis.  
Mitochondrial Isolation- Fresh tissues were minced and homogenized using an Ultra-Turrex 
Polytron (IKA, Staufen, Germany) at 9.8 Hz and subjected to differential centrifugation to 
separate intermyofibrillar (IMF) and subsarcolemmal (SS) mitochondria, as was done previously 
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(25). IMF mitochondria were treated with Nagarse, a proteinase from Bacillus lichenformis, to 
liberate the mitochondrial population. Fractions were subjected to a final centrifugation at 9000 
rpm to pellet mitochondria and were resuspended in resuspension buffer containing 100mM KCl, 
10mM MOPS and 0.2% BSA (pH 7.4). Concentrations were determined using Bradford method.  
Mitochondrial Respiration- Using a Clark Electrode (Strathkelvin Instruments, North 
Lanarkshire, Scotland), oxygen consumption was measured over time. Briefly, 50µL of 
mitochondria were incubated with 250µL of VO2 buffer (250mM sucrose, 50mM KCl, 25mM 
Tris base, 10mM K2HPO4 and pH 7.4) and continuously stirred at 30°C. Mitochondrial O2 
consumption was measured in the presence of 10mM glutamate to assess basal (state 4) 
respiration, followed by the addition of 0.44mM ADP for maximal (state 3) respiration. Integrity 
of the inner membrane was assessed through the addition of NADH during state 3 respiration. 
Respiratory rates were corrected for the total amount of protein. 
Mitochondrial ROS Emission- Mitochondria (75µg) were incubated in a 96-well plate with VO2 
buffer and 50uM 2’7’ dichlorofluorescin (DCF) at 37°C for 30 min. ROS emission was 
measured under state 3 and 4 respiratory conditions through the addition of ADP and glutamate 
or glutamate respectively. Fluorescence (excitation 480nm, emission 520 nm) was measured 
using a Synergy HT microplate reader (BioTek Instruments,VT, USA) and KC4 software (v.3.0), 
and was directly proportional to ROS emission.  
In Vitro Transcription, Translation and Protein Import- As previously described (32), plasmid 
DNA containing the ornithine transcarbamylase (OCT) cDNA and competent DH5α cells were 
transformed and grown on agar plates. Bacterial colonies were then amplified overnight in 
lysogeny broth  (LB) media and treated with ampicillin. Plasmid DNA was then isolated using a 
HiSpeed Plasmid Maxi Kit (Qiagen, Hilden, Germany). The DNA was then linearized using 
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Sca1 and subsequently purified using phenol and precipitated using ethanol. OCT was 
transcribed in vitro using SP6 polymerase for 90 min at 40°C. Translation was then carried out at 
37°C by combining rabbit reticulocyte lysate, mRNA, a cocktail of amino acids minus 
methionine, radio-labeled 35S methionine and water for 25 minutes.  
 As previously described (32), 75µg of freshly isolated mitochondria and 18µL of the 
translation mix were incubated for 30 min at 30°C to allow protein import. Mitochondria were 
then centrifuged through a sucrose gradient at 16,000g for 15 min at 4°C and resuspended in 
breaking buffer (0.6M sorbitol and 20mM HEPES) and lysis buffer (10% glycerol, 2.3% SDS, 
62.5mM Tris-HCl and 5% mercaptoethanol). Samples were denatured at 95°C for 5 min and 
then resolved through a 12% SDS-polyacrylamide gel for ~2 hr. Gels were then boiled for 5 min 
in 5% TCA, briefly washed with ddH2O, incubated with 10mM Tris for 5 min, followed by 30 
min in 1M salicyclic acid. Gels were then dehydrated at 80°C for 1hr and radiolabelled bands 
were captured on a Fujifilm Multipurpose Storage Phospho film and visualized using a Typhoon 
Scanner (GE Healthcare, Little Chalfont, UK).  
Protein Release Assay and Peptide Isolation- IMF mitochondria (150µg) from untreated 
C57BL/6 mice were incubated for 1hr at 30°C with or without the presence of 5mM H2O2, and 
FeSO4 to perturb the organelle and promote apoptosis. To assess whether or not peptides were 
being released from the mitochondrial permeability transition pore (mtPTP) basally and under 
stress, under the same conditions 200uM of cyclosporin A was added to block the opening of the 
mtPTP. Following incubation, mitochondria were pelleted by centrifugation (5 min at 14,000g at 
4°C) to collect all released material. Finally, the released fraction was separated based on size 
using a Spin-X Concentrator (Corning, MA, USA) collecting everything under 3kDa in size. 
Concentrations were determined spectrophotometrically using a NanoDrop 2000 (Thermo 
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Fisher, MA, USA).  
 This protocol was also used to isolate peptides for the import reactions with the exception 
that H2O2 and FeSO4 were not used to perturb the mitochondrion. Peptides were isolated under 
basal conditions in the presence of up to 600µg of mitochondria to increase peptide yield.  
Total RNA and Reverse Transcription- Approximately 100mg of pulverized gastrocnemius tissue 
was combined with 1mL of TRIzol Reagent (Invitrogen, CA, USA) and homogenized at 6Hz (3x 
10 sec) then mixed with chloroform. Samples were centrifuged at 16,000g for 15 min at 4°C. 
The aqueous phase was then transferred to a new tube and precipitated using isopropanol at -
80°C for 1hr. Samples were then once again centrifuged at 16,000g for 15 min at 4°C and pellets 
were resuspended in 30µL of molecular grade sterile water (Wisent Bio Products, QC, Canada). 
The concentration and purity of RNA were determined by spectrophotometer (NanoDrop 2000, 
Thermo Fisher, MA, USA). Superscript III reverse transcriptase (Invitrogen, CA, USA) was used 
according to manufacturer directions to convert 1.5µg of RNA into cDNA.  
Real-Time PCR- Primers were designed using sequences from GenBank, Primer 3 (v.0.4.0) 
software (Massachusetts Institute of Technology, MA, USA) and OligoAnalyzer 3.1 (Integrated 
DNA Technologies, ON, Canada) for genes of interest. mRNA expression was determined by 
combining SYBR Green Supermix (Quanta Biosciences, MD, USA), forward and reverse 
primers (20uM), stH2O and cDNA (10ng) in a 96-well plate. PCR amplification was carried out 
in a StepOnePlus Real-Time PCR System (Applied Biosystems, CA, USA) including a final 
melt-stage to check for nonspecific amplification. Results were corrected using two house-
keeping genes: β-actin and 18S ribosomal RNA.  
Protein Isolation- Frozen gastrocnemius muscle was pounded into a fine powder, of which 15-
20mg were diluted in 10x Sakamoto Buffer with the addition of protease and phosphatase  
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Table 1: A. In-vivo Morpholino sequences purchased from GeneTools, designed according to 
company guidelines targeted for Tim23 knockdown. B. List of primer sequences used for real-time 
PCR analysis. All primers are designed for mus musculus.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene In-Vivo Morpholino Sequence 
Tim23 5'-TCT TCC GCC ACC TTC CAT GAG GTC-3'  
Control 5’-CCT CTT ACC TCA GTT ACA ATT TAT A-3’ 
Gene  Primer 
Forward Reverse 
Ddit3 (CHOP) 5'-CAC CAC ACC TGA AAG CAG AA-3' 5'-AGG TGA AAG GCA GGG ACT CA-3' 
ATF5 5'-TGG AGC GGG AGA TCC AGT A-3' 5'-GAC GCT GGA GAC AGA CGT ACA-3' 
Hspa9 (mtHsp70) 5'-TGG CTA TTA CTG CGG GTT CT-3' 5'-CAT CTG CTC CAC CTC CTC T-3' 
Hspd1 (Hsp60) 5'-CTG GGT GCA AGA GCC ATA TA-3' 5'-GAA AGG CTG CTT CTG AAC TCT-3' 
Hspe1 (cpn10) 5'-GGA GTG CTG CTG CCG AAA CTG TA-3' 5'-TCA CAC TGA CAG GCT CAA TCT-3' 
Lonp1 (LonP) 
Timm23 (Tim23) 
5'-CGA CTT GCA CAG CCC TAT GT-3' 
5'-CCCGAGGCAGATTTGAACTA-3' 
5'-CGA ATG TTC CCG TAT GGT AGA T-3' 
5'-AAAGCCAGGGAGCCTAGAGTAT-3' 
B-actin 5'-TGT GAC GTT ACA TCC GTA A-3' 5'-GCT AGG AGC CAG AGG AGT AA-3'  
18S rRNA 5'-GTAACCCGTTGAACCCCATT-3' 5'-CCATCCAATCGGTAGTAGCG-3' 
A 
B 
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inhibitors (Sigma, MO, USA). Samples were then rotated at 4°C for 1hr and then sonicated (3x 3 
sec at 30% power). Samples underwent centrifugation at 14,000g at 4°C and the supernate was 
collected and stored at -80°C.  
Western Blotting- As previously described (24), whole muscle protein extracts were prepared 
and separated in polyacrylamide SDS-PAGE gels. Proteins were then transferred onto 
nitrocellulose membranes and blocked in 5%-10% milk in TBS-T. Subsequently, membranes 
were incubated with the appropriate concentration of primary antibodies overnight at 4°C, and 
then with HRP-conjugated secondary antibodies for 1hr at room temperature. Membranes were 
then visualized with enhanced chemiluminesence and a Carestream Model imaging system and 
Image J software was used for quantifications and corrected for with the appropriate loading 
control.  
Statistical Analysis- Unpaired t-tests were used to detect differences between Tim23 knockdown 
and control mice using GraphPad Prism 6.0. When comparing the effect of peptides on the 
import reaction or in the proteolysis experiments, paired t-tests or two-way ANOVA were used 
when appropriate. The critical value was set at p<0.05. All error bars represent the SEM.  
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Table 2: List of antibodies and concentrations used for Western blotting. All antibodies are prepared 
in 5% milk unless otherwise specified.   
Protein Manufacturer Catalog No.  Concentration 
Primary  Secondary  
Tim23 
BD Transduction 
Laboratories 611222 1:1000 1:2000 (M) 
COX IV Abcam ab140643 1:4000 1:4000 (M) 
Tfam In house --- 1:3000 1:5000 (R)  
mtHsp70 
Enzo Life 
Sciences ADI-SPA-810 1:1000 1:2000 (M) 
Hsp60 
Enzo Life 
Sciences ADI-SPA-806 1:1000 1:2000 (M) 
cpn10 
Enzo Life 
Sciences ADI-SPA-110 1:4000 1:4000 (R) 
ClpP Abcam ab124822 1:1000 1:1000 (R) 
LonP Cell Signaling 28020S 1:1000 1:2000 (R) 
ATF5 Abcam ab60126 
1:750  
(5% BSA) 1:3000 (R) 
CHOP Santa Cruz sc-7351 1:500 1:2500 (M) 
VDAC Abcam ab14734 1:5000 1:5000 (M) 
Aciculin In house --- 1:3000 1:3000 (M) 
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RESULTS 
Consequence of Tim23 Knockdown- Following In-Vivo Morpholino treatment, Tim23 protein 
content was significantly reduced in the IMF fraction by an average 40% (Figs. 1A, B). This 
corresponded to a 60% reduction in OCT import into the mitochondrial matrix in vitro (Fig. 1C). 
As expected the degree of Tim23 knockdown was strongly correlated to the level of impairment 
of import into the matrix (R2=0.533, p=0.01, Fig. 1D). Nuclear-encoded mitochondrial proteins 
were measured to assess whether or not this reduction in protein import affected the delivery of 
proteins to the organelle in vivo. COX IV, a subunit of the electron transport chain (ETC) located 
within the inner membrane was not changed in the IMF fraction (Fig. 1A). However, 
mitochondrial transcription factor A (Tfam) was significantly reduced by 25% (Fig. 1B) 
suggesting that partial loss of Tim23 selectively impairs protein import into the matrix both in 
vivo and in vitro.  
Maintenance of Mitochondrial Function Despite an Import Defect- Since Tim23 is the major 
channel of the TIM complex and is an integral part of the protein import process, we speculated 
that mitochondrial function would be impaired. In order to ascertain whether there was any 
mitochondrial dysfunction, mitochondrial respiration and ROS emission were assessed. 
Mitochondrial oxygen consumption both during state IV (basal) and state III (maximal) 
conditions were unchanged in the IMF fraction (Fig. 2A) of Tim23 knockdown animals. 
Similarly, during state IV respiration there was no difference found in ROS emission (Fig. 2B), a 
marker of oxidative stress, suggesting that mitochondrial function was maintained basally, 
despite a significant impairment in matrix-specific import. However, under maximal respiratory 
conditions there was a strong trend for increased ROS production (p=0.059; Fig. 2B). Suggesting 
that maximal mitochondrial function may be more susceptible to oxidative stress in the face of  
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Figure 1: Consequence of Tim23 knockdown. Representative western blots for Tim23, Tfam, 
COX IV and the loading control, VDAC in IMF fractions (A). Graphical representation for 
Tim23 and Tfam protein content following In-Vivo Morpholino treatment (B). Graphical 
representation of OCT import into the mitochondrial matrix with a corresponding blot (C). 
Correlation between Tim23 protein content and OCT import into the mitochondrial matrix (D; 
R2=0.533). (n=5-11. *, p<0.05; **, p<0.001). CTL, control; KD, knockdown; TL, OCT 
translation product alone. 		
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Figure 2: Maintenance of mitochondrial function despite import defect. Graphical 
representation of mitochondrial respiration during both state IV (basal) and state III (maximal) 
respiratory states (A). ROS production under the same respiratory conditions, corrected for 
oxygen consumption (B). (n=4-6) CTL, control IMF mitochondria; KD, knockdown IMF 
mitochondria. 	
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an import defect.  
Activation of the UPRmt Following Tim23 Knockdown- To assess whether partial loss of Tim23 
resulted in a perturbation of protein homeostasis, markers of the UPRmt were measured. To our 
surprise, ATF5, a novel proteolytic-dependent transcription factor, was unchanged (Fig. 3A). 
However, CHOP was elevated by 2.7-fold in the knockdown animals (Fig. 3B). Mitochondrial 
chaperones, mtHSP70 and HSP60, were unchanged in Tim23 knockdown animals (Fig. 3A), but 
chaperonin 10 (cpn10) was elevated by 40% (Fig. 3C). Similarly, of the resident proteases, LonP 
showed no change (Fig. 3A), however ClpP was increased by 1.8-fold (Fig. 3D). Taken together, 
it appears that a CHOP-dependent branch of the UPRmt may have been activated, following 
inhibition of protein import into the matrix. 
Next, we sought to investigate whether partial loss of Tim23 resulted in changes in 
mRNA expression. We had hypothesized that various protein quality control proteins would be 
upregulated in similar fashion to the protein data. However, both ATF5 and CHOP transcripts 
remained unchanged following Tim23 knockdown, and similarly no differences were observed 
in their downstream targets (Fig. 4).  
Understanding Proteolysis Within the Mitochondrion- To assess peptide release, mitochondria 
were isolated and incubated at 30°C for 30 minutes to allow basal proteolysis to occur with or 
without the presence of 5mM H2O2 to induce oxidative stress. These results demonstrate that 
proteolysis does occur basally and that the byproducts are exported into the cytosol. Thus, we 
sought to further perturb the organelle and assess how these protein fragments were exiting the 
mitochondrion. Mitochondria were incubated in the presence of H2O2 and FeSO4, to produce a 
hydroxyl radical (HO-). Under these conditions there was a significant increase in released 
peptides demonstrating an increased rate of proteolysis (Fig. 5). The addition of 200uM  
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Figure 3: Activation of the UPRmt following Tim23 knockdown. Representative western blots 
for mtHSP70, HSP60, cpn10, ClpP, LonP, in isolated IMF mitochondria; CHOP, and ATF5 in 
whole muscle extracts with their respective loading controls, VDAC and aciculin (A). Graphical 
representation of CHOP protein content in whole muscle extracts (B, p=0.05), Cpn10 (C, *, 
p<0.05) and ClpP in IMF mitochondria (D, p<0.05). Dashed line in ClpP blot indicates images 
taken from two separate blots. (CTL, n=7; KD, n=11). CTL, control; KD, knockdown. 	
  
mtHSP70 
HSP60 
Cpn10 
ClpP 
LonP 
 VDAC 
	
	
	
	
	
CTL   KD   CTL   KD 
ATF5 
Aciculin 
CHOP 
	
A 
B 
C 
D 
C
pn
10
 P
ro
te
in
 (A
.U
.) 
		 	
		 	
CTL KD 	0.0 
0.5 
1.0 
1.5 	 * 
C
H
O
P 
Pr
ot
ei
n 
(A
.U
.) 
		 	
		 	
CTL KD 	0.0 
0.2 
0.4 
0.6 
0.8 
1.0 	 * 
C
lp
P 
Pr
ot
ei
n 
(A
.U
.) 
CTL KD 	0.0 
0.5 
1.0 
1.5 	
		 	
		 	* 
			
		 59	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Changes in gene expression following Tim23 knockdown. mRNA expression of 
various UPRmt markers are expressed as fold changes over control values (n=6-8).  		
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Cyclosporin A was used under these same conditions to block the opening of the mitochondrial 
permeability transition pore (mtPTP), a nonselective channel on the outer membrane. The 
addition of cyclosporin A did not block the release of peptides from the mitochondria, thus 
eliminating the mtPTP as the channel through which the peptides were exported (Fig. 5).  
Role of Mitochondrially-Derived Peptides in Modulating Protein Import- The mechanism 
through which peptides influence retrograde signaling during the activation of the UPRmt is 
currently unknown. Thus, we investigated whether peptides may be influencing the UPRmt by 
modulating protein import. To test this hypothesis, peptides were isolated following basal 
proteolysis from mitochondria and incubated with radiolabeled OCT and freshly isolated 
mitochondria. Peptides were added to the import reaction in increasing doses (2, 4, and 6µg) with 
volume-matched controls. No effect of peptides on protein import was observed at 2 and 4ug, 
however 25% (p<0.05) decrease in import was apparent using 6ug of peptides (Fig. 6A). Next 
we asked if this relationship was also time-dependent by incubating 6µg of peptides for various 
time points (10, 20 and 30 min) since import itself is a time-dependent process. The inhibitory 
effect was not apparent at early times, but became evident after 30min of incubation (Fig. 6B). 
These data suggest that with increasing concentrations of peptides present this impairs protein 
import into the mitochondrial matrix.  
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Figure 5: Understanding proteolysis within the mitochondrion. Mitochondrial peptide release 
in the presense of H2O2 and FeSO4 with or without Cyclosporin A. CTL, control; Cyclo A, 
cyclosporin A. (**, P<0.001; n=6) 		
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Figure 6: Role of mitochondrially-derived peptides on protein import. Peptides incubated 
with import reactions at various doses, graph represents import rates as a percentage of their 
respective controls (A; p=0.06; 2, 4ug, n=6; 6ug, n=12). Import reactions in the presence of 6ug 
of peptides for various time points (10, 20 and 30 minutes) shown as a percentage of control (B; 
10, 20 min, n=5; 30 min, n=12). TL, translation product alone; CTL, control; RLS, 
mitochondrially-released peptides.  
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DISCUSSION 
 The maintenance of proteostasis is integral for the health of the cell(22, 34). Proteins that 
are misfolded or misassembled exert negative effects referred to as proteotoxicity, and this is 
combatted by compartment-specific protein quality control mechanisms known as the unfolded 
protein response (UPR) (28, 30). Mitochondrial biogenesis requires the contribution of protein 
products from both the nuclear and mitochondrial genomes. Thus, a mitochondrion must 
coordinate the expression of the nuclear genome, while also supporting the transcription and 
translation of its own gene products. Mitochondria are equipped with a protein import machinery 
(PIM) that facilitates the translocation of nuclear-encoded proteins (31), as well as a 
mitochondrion-specific UPR (UPRmt) that strives to maintain proteostasis (26, 36).  
In this study, we sought to better understand the UPRmt by inducing an imbalance 
between the two genomes. To achieve this, we knocked down the expression of Tim23, the 
major channel of the translocase of the inner membrane (TIM complex), using a systemically 
injectable anti-sense oligonucleotide, In-Vivo Morpholino. This treatment successfully reduced 
Tim23 protein in skeletal muscle IMF mitochondria to 60% of normal levels. We were not 
seeking a complete depletion of Tim23 levels, since homozygous deletion of Tim23 is 
embryonic lethal and thus critical for development (1). The consequence of this depletion was a 
functional impairment of protein import into the matrix, but not to other sub-compartments such 
as the inner membrane. This specificity is undoubtedly due to the complex nature of the PIM in 
which Tim23 mediates matrix-destined import but is not essential for translocation to other sub-
compartments (18). Tim22 is thought to operate in conjunction with, and independently from 
Tim23, to facilitate the passage of proteins directly into the inner membrane (23). In our 
experiments, this could also explain how mitochondrial respiration and ROS emission were 
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maintained basally despite this matrix import defect, since the electron transport chain (ETC) is 
found within the inner membrane. These data are in accordance with previous literature from the 
liver of Tim23 heterozygous and wildtype mice in which no differences in mitochondrial 
respiration were found (29). However, we did observe a tendency for elevated ROS emission 
during ADP-stimulated maximal respiration in mitochondria in which import was impaired. 
Thus, it appears that compositional changes brought upon by the import defect may only become 
evident during maximal respiration, leading to elevated ROS production. We had hypothesized 
that there would be an elevation in ROS in these animals because of the induction of structural 
imbalances in the stoichiometry of Krebs’ Cycle and electron transport chain subunits in the 
presence of an import defect. ROS are thought to mediate retrograde signaling to the nucleus 
through JNK, a mitogen-activated protein kinase. Work by Horibe et al. demonstrated that JNK 
activation was required for CHOP activation during UPRmt, however ROS were never measured 
in that study (31). Thus, the elevated ROS levels observed during state III respiration may, in 
part, explain the 2.7-fold increase in CHOP seen following Tim23 knockdown. 
 We also hypothesized that Tim23 knockdown in vivo would result in UPRmt activation. 
This was based on the research by Fiorese et al. who knocked down Tim23 in C. elegans to 
induce the UPRmt. This robustly activated ATFS-1, the homologue of ATF5 (12).  Interestingly, 
they also demonstrated that Tim23 knockdown also activates ATF5 when expressed in C. 
elegans (12). However, in our study no detectable changes in mRNAs encoding ATF5, CHOP, 
or their downstream targets were observed in the tissues collected 48hr following the last 
injection. Alterations in mRNA levels are transient events, and it is possible that these changes 
were occurring at an earlier timepoint. Thus, we sought to examine the protein level of various 
UPRmt markers via immunoblotting. This analysis revealed an increase in CHOP, the stress-
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induced transcription factor associated with UPR activation. ClpP and cpn10, a resident protease 
and chaperone respectively, were also both upregulated following Tim23 knockdown. Both ClpP 
and cpn10 are targets of CHOP, suggesting that the CHOP branch of the UPRmt was activated 
following Tim23 knockdown (17). However ATF5, a proteolytic-dependent transcription factor 
was not elevated, and neither were its downstream targets LonP, HSP60 and mtHSP70. These 
results provide evidence that the various branches of the UPRmt can act independently, and thus 
both transcription factors may not be needed for the maintenance of mitochondrial proteostasis. 
This appears to be different from stimuli that induce ER stress, where CHOP transcriptionally 
activates ATF5 to promote apoptosis (33).  Taken together, our results suggest that Tim23 
knockdown in vivo produces an import defect that results in modest mitochondrial dysfunction. 
This is likely involved in inducing proteotoxic stress, leading to the activation of the CHOP 
branch of the UPRmt, independent of ATF5. Therefore, even though Tim23 knockdown in C. 
elegans activates ATFS-1, our findings and those of others demonstrate that the activation of the 
UPRmt in mammalian models may differ from its counterpart in C. elegans.  
 Much of what we know about ATF5 is through work done on ATFS-1. It is thought that 
similar to ATFS-1, ATF5 is imported into the mitochondrion under basal conditions, and 
degraded. However, in the face of proteotoxicity, proteolytically-derived peptides are exported 
into the cytosol, thereby redirecting ATFS-1 into the nucleus where it acts as a transcription 
factor (17). However, it remains unclear how these peptides may influence the translocation of 
ATFS-1, or of other transcription factors, in the face of proteotoxicity. Thus, we sought to 
investigate potential mechanisms through which retrograde signaling may be activated, and we 
chose to focus on the role of mitochondrial proteolysis.  
Freshly isolated mitochondria left unperturbed will continue to proteolytically degrade 
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resident proteins and release the byproducts of this catabolism into the cytosol (4). Therefore, we 
incubated mitochondria to allow this basal proteolysis to occur, and then we collected all 
products released from the organelle that were under 3kDa. This includes all peptides that are 6-
30 amino acids in length, and therefore about 1kDa in size (15). Our data support previous 
literature that shows that peptides are released from mitochondria basally (4), and we 
demonstrated that excessive induction of oxidative stress promotes proteolysis and the 
subsequent release of peptides from the organelle. Next, we asked whether the mitochondrial 
permeability transition pore (mtPTP) could facilitate this export, since it is a channel that is 
opened during oxidative stress. However, treatment of mitochondria with Cyclosporin A, a 
known inhibitor of pore formation had no impact on peptide release (13). In C. elegans the 
mitochondrial channel, HAF-1, is necessary for the release of peptides from the organelle. 
Recently, Yano provided evidence for a mammalian homologue, ABCB10, and demonstrated its 
role in mediating UPRmt activation in HepG2 cells, however this channel does not seem to 
regulate peptide release (36). Therefore, it remains unclear which channel mediates the export of 
these proteolytically-derived peptides into the cytosol.  
 How could released peptides mediate retrograde signaling? Even in C. elegans this 
remains unknown, but a few possible mechanisms have been proposed. The first possibility is 
that peptides are being “sensed” by ATFS-1, or its mammalian homologue ATF5 (16, 21, 27). 
The second is that peptide efflux rate or volume is being monitored to influence ATF5 
translocation (21). We propose that peptides are influencing the import machinery to redirect the 
translocation of proteins from the mitochondrion to the nucleus. Work in yeast, and more 
recently in mammals, has demonstrated the dynamic nature of protein import and its ability to be 
modulated in response to its metabolic environment. This positions the PIM as a sensor of 
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mitochondrial health status, and a means of communicating this throughout the cell (14). An 
example of this is during the process of mitophagy, where PINK1 is regularly imported into the 
matrix, but under stress is arrested on the outer membrane, thereby initiating mitophagy. Thus, 
we asked whether proteolytic byproducts could modulate protein import as a potential retrograde 
signal to communicate proteotoxic stress. We incubated peptides at various doses and found that 
import capacity was reduced in the presence of peptides in a dose- and time-dependent manner. 
These findings fit with the idea that low concentrations of peptides, which are continuously 
exported from mitochondria due to basal proteolysis, would remain innocuous. However, higher 
concentrations of peptides representing stress-induced elevations in protein breakdown would 
exert signaling consequences. For example, peptide-dependent import inhibition could serve to 
redirect ATF5 or other proteins to the nucleus to induce compensatory gene expression, while at 
the same time reducing new sources of proteotoxic stress directed toward the organelle’s PIM. It 
remains to be addressed whether peptides could in fact influence ATF5 directly, or through some 
intermediary signaling step.  
 In summary, these results demonstrate that Tim23 knockdown in vivo disrupts protein 
import resulting in a mito-nuclear imbalance that selectively activates the CHOP-branch of the 
UPRmt, independent of ATF5. In addition, our data highlight a potential mechanism in which 
protein import is modulated by the presence of mitochondrially-derived peptides in the cytosol to 
communicate proteotoxic stress within the mitochondrion to the nucleus. Better understanding of 
the UPRmt and its retrograde signals would provide much needed insight into the mitochondrial 
stress response, which has been implicated in a variety of cancers, neurodegenerative diseases 
and aging.  
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FUTURE WORK 
1. Our data indicate that the CHOP-branch of the UPRmt can be activated independently 
from ATF5. During the activation of the UPRmt, CHOP and ATF5 respond to different 
stress signals to transcriptionally regulate a wide variety of mitochondrial chaperones and 
proteases. Future work should address whether these transcription factors are able to act 
in a compensatory fashion, or if they rely on one another for the complete maintenance of 
proteostasis.  
2. Our model of mitochondrial proteotoxic stress resulted in the selective activation of 
CHOP and elevations in its downstream targets. Previous work identified mitochondrial 
unfolded protein response elements (MURE) that flank the CHOP binding site within the 
promoters of its targets. Mutation of these MURE sites blunts their response to 
mitochondrial stress, however it is still unknown what factors bind to these elements. By 
performing a CHIP assay or an electromobility shift assay, we could test the binding of 
transcription factors that are thought to be associating with the UPRmt such as SatB5 and 
UBL5. These transcription factors were originally discovered in C. elegans but their role 
in the mammalian UPRmt has not been assessed. 
3. In contrast to our findings, Tim23 knockdown in C. elegans has been shown to activate 
the homologue of ATF5, ATFS-1. Therefore despite the evolutionary conservation of the 
UPRmt there appears to be some discrepancy between species. Other groups have also 
described this inconsistency, and it appears that this may be due to the fact that the 
mammalian UPRmt lies in the midst of an interconnected stress network. Therefore in 
order to understand the maintenance of proteostasis in mammals, it would be beneficial to 
understand how other stress responses, such as the integrated stress response, ATF4-
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dependent mitochondrial stress pathway and others, may be coordinated to maintain 
cellular health.  
4. For the isolation of peptides our current study employed a technique that allowed the 
collection of released products under 3kDa. Previous studies have used peptide columns 
and HPLC to selectively isolate mitochondrially-released peptides. Our methodology 
provided a cost- and time-efficient alternative and provided some preliminary data to 
guide future experimentation. However, it is possible that our released fraction may 
contain other factors besides peptides. Therefore, future experiments will incorporate the 
use of HPLC to specifically isolate peptides of 6-30 amino acids. This will help 
definitively address the role of peptides in modulating protein import.  
5. Our study on the role of proteolysis and retrograde signaling addressed but one 
hypothesis, however there are other proposed mechanisms that have yet to be tested. For 
instance, it is possible that the peptides may directly influence ATF5, thereby redirecting 
its translocation from the mitochondrion to the nucleus.  
6. Our model of proteotoxic stress involved perturbing the expression import machinery. 
However, this resulted only in the activation of the CHOP-branch of the UPRmt. Future 
work could attempt to induce proteotoxicity without genetic manipulation. For example, 
exercise has been shown to activate both the UPR of the mitochondria and the 
endoplasmic reticulum. It is thought that the UPR is activated to support the heightened 
exercise-induced volume of protein synthesis and ensure their proper folding and 
maturation.  
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APPENDIX A: DATA TABLES AND STATISTICAL ANALYSES 
 
 
Table 1A: Tim23 protein data of control and knockdown animals. 
 
 
 
 
Table 1B: Tfam protein data of control and knockdown animals. 
 
 
 
Tim23 Protein Data (A.U.) 
N CTL KD 
1 0.9709826 0.2412409 
2 0.8816105 0.3072163 
3 0.7520235 0.4386753 
4  0.5208293 
5 0.7073644 0.4778115 
6 1.026959 0.5134783 
7 0.9541969 0.5589802 
8 - 0.5159158 
9 - 0.5794561 
10 - 0.8611497 
11 - 0.8873845 
AVG 0.8822 0.5366 
SEM 0.0521 0.0592 
Unpaired T-Test 
P value 0.0015 
P value Summary ** 
Significantly Different? (P≤0.05) Yes 
Tfam Protein Data (A.U.) 
N CTL KD 
1 1.150407  
2 1.181901 0.9389503 
3 0.6448731  
4 0.7689064 0.4469627 
5 0.7000248 0.5118412 
6 0.9533582 0.5207944 
7 1.043469 0.7216239 
8 - 0.8199509 
9 - 0.6279679 
10 - 0.8812299 
11 - 0.7413225 
AVG 0.9204 0.6901 
SEM 0.0824 0.0580 
Unpaired T-Test 
P value 0.0336 
P value Summary * 
Significantly Different? (P≤0.05) Yes 
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Table 1C: COX IV protein data from control and knockdown animals.  
 
 
 
 
 
Table 1D: OCT import into the mitochondrial matrix of control and knockdown animals. 
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Table 1E: Correlation between Tim23 protein content and OCT protein import. 
 
 
 
 
 
 
 
Table 2A: Mitochondrial oxygen consumption during state III and state IV respiration in 
IMF mitochondria of control and knockdown animals. 
 
 
 
 
 
O2 Consumption State III 
(natoms of O2/mg/min) 
N CTL KD 
1 26.344 128.89 
2 69.55 127.92 
3 107.04 36.26 
4 78 16.71 
5 - 64.53 
6 - 80.86 
7 - 65.01 
AVG 70.23 74.31 
SEM 16.69 16.07 
O2 Consumption State IV 
(natoms of O2/mg/min) 
N CTL KD 
1 4.884 34.91 
2 3.16 50.63 
3 24.24 13.55 
4 7.04 5.56 
5 - 14.45 
6 - 16.34 
7 - 18.77 
AVG 9.83 22.03 
SEM 4.87 5.83 
Unpaired T-Test 
P value 0.8734 
P value Summary NS 
Significantly Different? (P≤0.05) No 
Unpaired T-Test 
P value 0.1918 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 2B: ROS emission during state III and IV respiration in IMF mitochondria of 
control and knockdown animals. 
 
 
 
 
Table 3A: mtHSP70 protein data from control and knockdown animals.  
 
 
 
 
ROS Emission State III 
(ROS/ natoms O2 consumed) 
N CTL KD 
1 1.16 3.48 
2 1.04 3.51 
3 0.65 0.83 
4 0.93 2.33 
5 0.55 1.38 
6 - 1.02 
7 - 1.31 
AVG 0.87 1.98 
SEM 0.11 0.43 
ROS Emission State IV 
(ROS/ natoms O2 consumed) 
N CTL KD 
1 7.43 11.73 
2  8.520001 
3 3.53 2.69 
4 7.35 6.95 
5 - 6.64 
6 - 3.2 
7 - 3.01 
AVG 6.10 6.11 
SEM 0.11 0.43 
Unpaired T-Test 
P value 0.0598 
P value Summary ns 
Significantly Different? (P≤0.05) No 
Unpaired T-Test 
P value 0.9991 
P value Summary ns 
Significantly Different? (P≤0.05) No 
mtHSP70 Protein Data (A.U.) 
N CTL KD 
1 0.833247 0.773398 
2 0.8547752 0.7959417 
3 1.064442 1.084773 
4 0.9361669 1.412059 
5 1.38914 2.117404 
6 0.9280701 1.175649 
7 1.053496 0.9443448 
8 - 1.058178 
9 - 0.9780438 
10 - 1.230151 
11 - 0.9541746 
AVG 1.0085 1.1386 
SEM 0.0717 0.1128 
Unpaired T-Test 
P value 0.4098 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 3B: HSP60 protein data from control and knockdown animals. 
 
 
 
 
 
Table 3C: cpn10 protein data from control and knockdown animals. 
 
 
 
 
 
 
 
HSP60 Protein Data (A.U.) 
N CTL KD 
1 0.5397548 0.4589969 
2 0.6180008 0.8974862 
3 0.6849582 0.6328499 
4 0.6082724 1.04916 
5 0.8928078 0.9006587 
6 1.057783 0.4796593 
7 - 0.8257073 
8 - 0.7353758 
9 - 1.117737 
10 - 0.9781952 
AVG 0.7336 0.8076 
SEM 0.0815 0.0719 
Unpaired T-Test 
P value 0.5216 
P value Summary NS 
Significantly Different? (P≤0.05) No 
cpn10 Protein Data (A.U.) 
N CTL KD 
1  1.504431 
2 0.6228833 2.025082 
3 0.7957519 0.8345317 
4 0.784143 1.232726 
5 1.183278 1.421117 
6 0.9724378 1.430972 
7 0.8189973 0.9539758 
8 - 0.7813434 
9 - 1.122589 
10 - 1.022741 
11 -  
AVG 0.8629 1.2330 
SEM 0.0717 0.1128 
Unpaired T-Test 
P value 0.4098 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 3D: LonP protein data from control and knockdown animals. 
 
 
 
 
 
 
Table 3E: ATF5 protein data from control and knockdown animals. 
 
 
 
 
 
 
 
 
 
LonP Protein Data (A.U.) 
N CTL KD 
1 0.6195474 0.3061144 
2 0.6195693 0.9700184 
3 0.4513356 0.7766681 
4 0.6662512 0.8779618 
5 0.6959335 0.9626596 
6 - 0.2159032 
7 - 0.4266551 
8 - 0.5309769 
9 - 0.6353779 
AVG 0.6105 0.6336 
SEM 0.0717 0.1128 
Unpaired T-Test 
P value 0.8643 
P value Summary NS 
Significantly Different? (P≤0.05) No 
ATF5 Protein Data (A.U.) 
N CTL KD 
1 0.7743397 1.385935 
2  1.023056 
3 1.592352 0.6377682 
4 0.6868413 0.8388594 
5 0.7338548 0.8105195 
6 1.114785 1.462193 
7 0.9051485 1.380047 
8 - 0.7651758 
9 - 1.428164 
10 - 0.8455867 
AVG 0.9679 1.0577 
SEM 0.0717 0.1128 
Unpaired T-Test 
P value 0.6053 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 3F: CHOP protein data from control and knockdown animals. 
 
 
 
 
 
 
Table 4A: cpn10 mRNA data from control and knockdown animals. 
 
 
 
 
 
 
 
 
 
cpn10 mRNA Data (ΔCT) 
N CTL KD 
1 2.171846 1.87155 
2 1.712675 3.336012 
3 1.609414 2.400604 
4 0.8588074 1.205472 
5 2.301737 1.717492 
6 3.185344 2.76584 
7 2.758926 3.623366 
8  3.784026 
9 - 3.120884 
AVG 2.0855 2.6472 
SEM 0.2923 0.3019 
Unpaired T-Test 
P value 0.2116 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 4B: LonP mRNA data from control and knockdown animals. 
 
 
 
 
 
 
Table 4C: HSP60 mRNA data from control and knockdown animals. 
 
 
 
 
 
 
 
 
 
 
LonP mRNA Data 
N CTL KD 
1 0.7548169  
2 0.9568937 0.9602019 
3 1.101486 0.54255 
4 0.5024896 0.6155571 
5 1.685142 1.2605 
6 1.124732 1.745178 
7 0.764742 0.8029145 
8 1.336282 1.078348 
9 - 0.8123369 
AVG 1.0283 0.9772 
SEM 0.1314 0.1374 
Unpaired T-Test 
P value 0.7919 
P value Summary NS 
Significantly Different? (P≤0.05) No 
Hsp60 mRNA Data (ΔCT) 
N CTL KD 
1 1.722142 1.314453 
2 0.9785895 0.923695 
3 1.424187 2.068885 
4 0.726134 1.091315 
5 2.167586 1.513709 
6 2.125198 2.505007 
7 2.141938 2.556027 
8 3.651004 2.714573 
9 - 2.043776 
AVG 1.8671 1.8590 
SEM 0.3197 0.2234 
Unpaired T-Test 
P value 0.9835 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 4D: mtHSP70 mRNA data from control and knockdown animals. 
 
 
 
 
 
 
Table 4E: CHOP mRNA data from control and knockdown animals.  
 
 
 
 
 
 
 
 
 
 
 
mtHSP70 mRNA Data (ΔCT) 
N CTL KD 
1 1.907764 1.030411 
2 0.713637 0.9519883 
3 1.001654 1.703628 
4 0.5558497 0.8947718 
5 1.514157 1.087605 
6 1.644336 1.684619 
7 1.289915 1.336527 
8 2.364284 1.420414 
9 - 1.407776 
AVG 1.3739 1.2797 
SEM 0.2159 0.1012 
Unpaired T-Test 
P value 0.6873 
P value Summary NS 
Significantly Different? (P≤0.05) No 
CHOP mRNA Data (ΔCT) 
N CTL KD 
1 0.9654048 1.215488 
2 0.5072798 1.654349 
3 0.483783 0.6409809 
4 0.283044  
5 1.131608 0.551734 
6 0.821074 0.971155 
7 0.414419 0.62835 
8 0.772394 0.521684 
9 - 0.483822 
AVG 0.6724 0.8334 
SEM 0.1044 0.1474 
Unpaired T-Test 
P value 0.3875 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 4F: ATF5 mRNA data from control and knockdown animals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ATF5 mRNA Data (ΔCT) 
N CTL KD 
1 0.3281052  
2 1.030194 1.32043 
3 1.253029 0.4327194 
4 0.5011962 0.4422385 
5 1.770217 1.138875 
6 1.390195 2.2088 
7 1.645271 3.463086 
8 2.232759 1.699408 
9 - 1.280162 
AVG 1.2689 1.4982 
SEM 0.2263 0.3501 
Unpaired T-Test 
P value 0.5909 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 5: Peptide Release from IMF mitochondria under oxidative stress conditions, H2O2 
and FeSO4. 
 
  
 
 
 
 
 
 
 
 
Peptide Release Data (ug/uL) 
N CTL Cyclosporin A 
CTL H2O2 H202+FESO4 CTL H2O2 H202+FESO4 
1 0.44 0.56 1.3 0.8 0.97 2.05 
2 0.64 0.62 1.85 1.4 1.29 2.95 
3 0.53 0.39 2.14 0.74 0.48 2.15 
4 0.45 0.57 2.08 0.6 0.52 1.67 
5 0.51 0.51 0.7 0.53 0.56 0.83 
6 0.518 0.615 0.9 0.605 0.535 0.77 
AVG 0.5147 0.5442 1.4950 0.7792 0.7258 1.7367 
SEM 0.2923 0.3019 0.3019 0.3019 0.3019 0.3019 
Repeated Measures 2-Way ANOVA 
Source of Variation P value P value Summary  Significant? 
Interaction 0.7575 NS No 
Cyclosporin A 0.1883 *** Yes 
Oxidative Stress 0.0008 NS No 
Bonferroni Post Hoc Test-Contol vs. Oxidative Stress 
Condition Difference T P value Summary 
H202 0.01192 0.05922 P>0.05 NS 
H2O2+FeSO4 -0.9689 4.815 P<0.001 ** 
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Table 6A: OCT protein import into the matrix of IMF mitochondria in the presence of 2ug 
of peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6B: OCT protein import into the matrix of IMF mitochondria in the presence of 4ug 
of peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein Import with 2ug Peptides 
(Imported OCT/ Total OCT) 
N CTL 2ug PEP 
1 0.32 0.31 
2 0.39 0.4 
3 0.39 0.37 
4 0.37 0.44 
5 0.51 0.5 
6 0.51 0.49 
AVG 0.4150 0.4183 
SEM 0.0318 0.0298 
Paired T-Test 
P value 0.822 
P value Summary NS 
Significantly Different? (P≤0.05) No 
Protein Import with 4ug Peptides 
(Imported OCT/ Total OCT) 
N CTL 4ug PEP 
1 0.38 0.45 
2 0.37 0.44 
3 0.45 0.43 
4 0.44 0.45 
5 0.48 0.46 
6 0.44 0.45 
AVG 0.4267 0.4467 
SEM 0.0175 0.0042 
Paired T-Test 
P value 0.2856 
P value Summary NS 
Significantly Different? (P≤0.05) No 
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Table 6C: OCT protein import into the matrix of IMF mitochondria in the presence of 6ug 
of peptides for 10 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6D: OCT protein import into the matrix of IMF mitochondria in the presence of 6ug 
of peptides for 20 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein Import with 6ug Peptides-10 
min (Imported OCT/ Total OCT) 
N CTL 6ug PEP 
1 0.13 0.15 
2 0.38 0.4 
3 0.38 0.4 
4 0.43 0.33 
5 0.31 0.45 
AVG 0.3260 0.3460 
SEM 0.0526 0.0526 
Paired T-Test 
P value 0.626 
P value Summary NS 
Significantly Different? (P≤0.05) No 
Protein Import with 6ug Peptides-20 
min (Imported OCT/ Total OCT) 
N CTL 6ug PEP 
1 0.32 0.39 
2 0.49 0.48 
3 0.47 0.42 
4 0.47 0.39 
5 0.4 0.33 
AVG 0.4300 0.4020 
SEM 0.0315 0.0244 
Paired T-Test 
P value 0.3627 
P value Summary NS 
Significantly Different? (P≤0.05) No 
  
 87 
Table 6E: OCT protein import into the matrix of IMF mitochondria in the presence of 6ug 
of peptides for 30 minutes. 
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APPENDIX B: SUPPLEMENTAL DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: Tim23 mRNA levels following In-Vivo Morpholino treatment. (n=8-9) CTL, control; 
KD, knockdown. 
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Figure S2: Graphical representation of mitochondrial respiration from SS mitochondria during 
both state IV (basal) and state III (maximal) respiratory states (A). ROS production under the 
same respiratory conditions, corrected for oxygen consumption (B). (n=3-5) CTL, control SS 
mitochondria; KD, knockdown SS mitochondria  
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Figure S3: Concentration of peptides released from the mitochondria following 30 minutes 
incubation with various doses of H2O2 at 30ºC. (n=4). 
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APPENDIX C: LABORATORY METHODS AND PROTOCOLS 
 
IN-VIVO MORPHOLINO TREATMENT         
Reference: Ferguson DP, et al. Biotech, 2015, 56:251-256. 
 
 In-Vivo Morpholinos are shipped as a sterile lyophilized solid and can be diluted with 
either sterile water or phosphate-buffered saline (PBS) as per the company’s recommendation.  
Stock may be kept at room temperature for about a year. You may autoclave the stock after a 
year and continue using.  
 
 GeneTools will provide a product sheet containing information such as molecular weight, 
and weight of the product. Each oligo will differ in these values based on the sequence 
synthesized.  
 In-Vivo Morpholino can be used locally or systemically, with good delivery to most 
major organs (liver, small intestine, colon, muscle, lung, and stomach tissues) via an intravenous 
or intraperitoneal injection. Delivery has been demonstrated to a lesser extent in the spleen, 
heart, skin and brain.  
 
For systemic delivery: 
1. Weigh mouse prior to the first injection 
2. Prepare injection at a dose of 12.5mg/kg of body in a sterile 29 G x1/2 syringe 
3. Restrain the mouse by holding them by the scruff of the neck and the base of the tail, thus 
exposing the belly. Or by using a cloth, create a small pocket for the mouse to crawl into, 
hold the animals back and raise the tail, exposing the intraperitoneal cavity.  
4. Locate the intraperitoneal space, just medial to the thigh, and inject the animal. Minimal 
resistance should be felt when piercing this cavity.  
5. Monitor the animal for a while after, typically there are little to no signs of discomfort.  
6. Injections are given once daily for 3 consecutive days, following steps 2-5. Tissues may 
be harvested 48hrs following the last injection.  
 
MITOCHONDRIAL ISOLATIONS FROM MUSCLE        References:  Cogswell et al. Am J Physiol, 1993, 264: C388-C389                    Krieger et al. J Appl Physiol, 1980, 48: 23-28 
Reagents:  
All buffers are set to pH 7.4 and stored at 4 °C  
- Buffer 1       - Buffer 1 + ATP  
100 mM KCl       Add 1 mM ATP to Buffer 1  
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5 mM MgSO4  
5 mM EDTA  
50 mM Tris base  
- Buffer 2      - Resuspension medium  
100 mM KCl       100 mM KCl  
5 mM MgSO4      10 mM MOPS  
5 mM EGTA       0.2% BSA  
50 mM Tris base  
1 mM ATP  
- Nagarse protease (Sigma, P-4789) 
10 mg/ml in Buffer 2  
Make fresh for each isolation, keep on ice  
 
Procedure:  
 
1. Remove various muscles from mouse and place in a scintillation vial containing ice cold 
buffer 1.  
2. Place muscles on a watch glass that is also on ice and trim away fat and connective tissue. 
Proceed to thoroughly mince the muscle sample with forceps and scissors, until no large 
pieces are remaining.  
3. Place the minced tissue in a plastic centrifuge tube and record the exact weight of tissue.  
4. Add a 10-fold dilution of Buffer 1 + ATP to the tube.  
5. Homogenize the samples using the Ultra-Turrax polytron with 40% power output (9.8 
Hz) and 10 sec exposure time.  
6. Using a Beckman JA 25.50 rotor, spin the homogenate at a centrifuge setting of 800 g for 
10 min. This step divides the IMF and SS mitochondrial subfractions. The supernate will 
contain the SS mitochondria and the pellet will contain the IMF mitochondria. 
SS mitochondrial isolation:  
7. Filter the supernate through a single layer of cheesecloth into a second set of 50 ml 
plastic centrifuge tubes.  
8. Spin tubes at 9000 g for 10 min. Upon completion of the spin discard the supernate and 
gently resuspend the pellet in 3.5 ml of Buffer 1 + ATP. Since the mitochondria are easily 
damaged, it is important that the resuspension of the pellet is done carefully.  
9. Repeat the centifugation of the previous step (9000 g for 10 min) and discard the 
supernate.  
10. Resuspend the pellet in 100 μl of Resuspension medium, being gentle so as to prevent 
damage to the SS mitochondria. Some extra time is needed during this final resuspension 
to ensure the SS pellet is completely resuspended.  
11. Keep the SS samples on ice while proceeding to islolate the IMF subfraction.  
IMF mitochondrial isolation: 
7. Gently resuspend the pellet (from step 6) in a 10-fold dilution of Buffer 1 + ATP using a 
teflon pestle.  
8. Using the Ultra-Turrax polytron set at 40% power output, polytron the resuspended pellet 
for 10 s. Rinse the shaft with 0.5 ml of Buffer 1 + ATP.  
9. Spin at 800 g for 10 min and discard the resulting supernate.  
10. Resuspend the pellet in a 10-fold dilution of Buffer 2 using a teflon pestle.  
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11. Add the appropriate amount of nagarse. The calculation for the appropriate volume is 
0.025 ml/g of tissue. Mix gently and let stand exactly 5 min.  
12. Dilute the nagarse by adding 20 ml of Buffer 2.  
13. Spin the diluted samples at 5000 g for 5 min and discard the resulting supernate.  
14. Resuspend the pellet in a 10-fold dilution of Buffer 2. Gentle resuspension is with a 
teflon pestle.  
15. Spin the samples at 800 g for 10 min. Upon the completion of the spin, the supernate is 
poured into another set of 50 ml plastic tubes (on ice), and the pellet is discarded.  
16. Spin the supernate at 9000 g for 10 min. The supernate is discarded and the pellet is 
resuspended in 3.5 ml of Buffer 2.  
17. Spin samples at 9000 g for 10 min and discard the supernate.  
18. Gently resuspend the pellet in 200 μl of Resuspension medium.  
 
MITOCHONDRIAL RESPIRATION          
Reference: Estabrook, R.W., Meth. Enzymol., 10: 41-47 (1967) 
 
The rate of mitochondrial respiration is an important consideration in the biochemical 
analysis of mitochondria.  There are three phases of interest in analyzing the respiratory ability of 
mitochondria.  Mitochondria produce ATP in the presence of oxygen.  The respiratory ability of 
the freshly isolated IMF and SS mitochondrial fractions and the homogenates can be illustrated 
by measuring the rate of oxygen consumption using a Clark oxygen electrode in the presence of 
a) the substrate alone (e.g. glutamate for state 4 or resting respiration); b) ADP, (state 3 or active 
respiration); and c) NADH+, which is used to measure the amount of damage that has occurred to 
the mitochondria, since the inner membrane is impermeable to NADH+. 
 
Reagents: 
  
1.    VO2 Buffer for muscle mitochondria: 
 
250 mM Sucrose  42.8 g/500 ml 
     50 mM KCl 1.86 g/500ml 
     25 mM Tris-HCl * 1.97 g/500ml             
     10 mM K2HPO4  0.871 g/500ml 
  pH to 7.4 
 * In place of 25mM Tris-HCl you can use 25 mM Tris (aka Tris (hydroxymethyl) 
methylamine).  This works out  to 1.5125 g/500ml (FW=121.4).  Using Tris in 
place of Tris-HCl means that you will have to add more HCl to get the pH down 
to 7.4 
2.  Glutamate - final conc. of 11.1 mM.............................2.0 M initial conc. (406.4 mg/ml) 
3. ADP - Final conc of 0.44 mM ..................................... 20 mM initial conc.  (8.54 mg/ml)  
4.  NADH - Final conc.: 2.8 mM........................................0.5 M initial conc. (354.7 mg/ml) 
  
Procedure: 
 
 1.  Set water bath at 30oC -- clean out chambers (Clark oxygen electrode; Yellow Springs Inst. 
Co., Yellow Springs, OH) and stir bars. 
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 2.  Add 250uL of VO2 Buffer to each chamber. 
 3.  Insert electrode # 2 into the chamber. 
 4.  Remove all bubbles in the chamber and allow it to reach equilibrium temperature (30oC) 
while spinning. 
 5.  Set recorder for chamber # 2 and paper speed for 3 cm/min.  
 6.  Set monitor and recorder to 100 %. 
 7.  Remove electrode.  Add 50 µl of mitochondria into the chamber. 
8.  Allow a steady state to be reached. 
 9.  Add 12.5 µl of pyruvate and 12.5 µl of malate (heart) or 12.5 µl glutamate (muscle).  
10.  Wait approximately 3 minutes then add ADP: 50 µl for muscle, 100 µl for heart. 
11.  Wait (about 2-3 minutes) for a steady rate of state 3 respiration before adding 12.5 µl of 
NADH.  Prepare the next chamber while the respiration recordings are being made. 
12.  Clean out the chamber in the following manner : Remove the electrode and aspirate, remove 
the magnetic stir bar and aspirate, and finally, clean the electrode by rinsing with distilled 
water and pat dry. 
13.  Put electrode in the next chamber (which should already have the buffer and sample in it).  
14.  Prepare the next chamber while the measuring the respiration of the current chamber (ie. add 
2 ml of VO2 Buffer and allow to equilibrate). 
15.  Calculate the state 4, state 3 and NADH+ rates for each sample. Remember that the chart 
speed is 3 cm/sec and full scale is 100 %. (slope=rate=blocks/min) 
16. Calculate the rates of state 3 and state 4 respiration per mg of mitochondrial protein by 
dividing the state 3 and 4 rates by the amount of protein (mg) added to the VO2 Buffer.    Calculate the Respiratory Control Ratio (RCR):  RCR = state 3 rate/ state 4 rate For the above ratio you need only use slopes from the graph.  However, for exact calculations of the state 3 and state 4 rates follow the method below:  References: Biological Oxygen Monitor Instruction Manual (table 1, p.13).     Chappel, J.B. Biochem. J. (1964) 90:225-237 
x Assume a barometric pressure of 1 atm. (760 mmHg).  At 1 atm. the amount of 
oxygen dissolved in medium equals 5.47 µl O2/ml (value taken from Biological 
Oxygen Monitor Instruction Manual).  Since 2 ml are being used in the chamber, 
total O2 is equal to 2 x 5.47 = 10.94 µl.  The rate of change from 100% O2 can 
then be used to calculate the amount of O2 consumed per unit time: State 3 or 4 /mg protein x 10.94 µl O2           100% 
x But the units of O2 consumed are now typically expressed in units of natoms 
O2.   Thus, State 3 or 4 /mg prot. x 968 natoms O2 = x natoms O2/mg prot./min.       100% 
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ROS EMISSION            
 
Background: Mitochondria are the primary source of reactive oxygen species (ROS) to the cell.  It is estimated that about 2% of total cellular oxygen is converted ROS by the inappropriate reduction of molecular oxygen by intermediate members of the electron transport chain (ETC).  ROS are damaging molecules that are capable of compromising the integrity of macromolecules within the mitochondria and may lead to overall organelle dysfunction.  In particular, mtDNA may be prone to attack by ROS because 1) mtDNA is located in close proximity to the ETC, 2) mtDNA lacks the protective sheath of histones compared to nuclear DNA and, 3) mitochondria have an insufficient repair system for mtDNA mutations.   ROS can exist in a variety of molecular permutations such as superoxide  (O2-), hydroxyl radical (OH-) and hydrogen peroxide (H2O2).    DCF (2,7,-dichloro-fluorescein; Fig.1) is a reagent that is non-fluorescent until the acetate groups are removed by intracellular esterases and oxidation occurs within the mitochondria (Fig.1).  DCF is oxidized by all of the different forms of ROS and this can be detected by monitoring the increase in fluorescence with a fluorometric plate reader.  The appropriate plate reader filter settings for fluorescein are the following: Excitation 
485/20 and Emission 528/20 (Fig.2).  
   
   Fig.1-DCF molecule and oxidation of DCF resulting in fluorescence 
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Fig.2-Absorption and Emission Spectra of oxidized dye               
 
KC4 Software Settings: The Settings icon in the upper left corner allows the alteration of various parameters.  Once clicked, another window appears, click on the Wizard Icon.  In this window there will be a variety of components that can be altered.  The following are the parameters that need to be changed in order to utilize the DCF and measure time-dependent ROS production from isolated mitochondria:  1) Top Middle Panel- Absorbance, Fluorescence, Luminescence- choose Fluorescence 2) Top Left Panel- End Point, Kinetic, Spectrum- choose Kinetic 3) Top Middle Panel- Click on larger box labeled Kinetic to set parameters- Run Time 
1:20:00, Interval 5:00 (takes a measure every 5 minutes), click on box labeled Allow 
Well Zoom during Read, and also click on box labeled Individual Well Auto Scaling- The Well Zoom and Auto scaling allows for monitoring each individual well during the experiment and scales it appropriately. 4) Middle Panel-Filter Set- Choose #1, then set the excitation to 485/20, and emission to 
528/20 as described above.  The optics position should be set to the TOP (i.e. readings are taken from the top of the well) and the sensitivity is set at 50 (depending upon the amount and/or nature of the sample).  5) Plate-Type-choose 96-well plate, choose which wells are to be read i.e. A1-C12. 6) Shaking-Intensity set at 1, Duration set at 15s and then click the box that is labeled 
before every reading (it shakes the samples for 15 s before every reading). 7) Temperature Control- Click on the box indicating YES, also click on box labeled pre-heating, and put 37°C into the temperature box. 
 
Reagents:  DCF (2,7,-dichlorodihydrofluorescein diacetate) reagent MW=487.29 (Molecular Probes D-399/ 100mg)  
1° STOCK- Make up 50mM Stock Solution in EtOH- 24 mg/ml- only make about 500ul i.e. 14 mg per 500ul EtOH. Wrap stock solution in aluminum foil and limit exposure to light since DCF is light-sensitive.  
Working Stock Solution-2° STOCK- Dilute 50mM by 100-fold by taking 10ul and adding 990 ul of EtOH to attain a 500uM DCF Stock Solution.  This will be the DCF concentration used to add to the reaction mixture.  VO2 Buffer- refer to mitochondrial respiration protocol  
Procedure:  1. SS and IMF mitochondria are isolated as described in the mitochondrial isolation protocol.  Alternatively, frozen mitochondrial extracts can also be used.  2. Determine the volume necessary for 50ug of mitochondria.  Typical volumes should range between 5-40ul depending upon concentration of mitochondrial extracts. 
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3. Final concentration of DCF is 50uM.  The total volume of the reaction mixture is 250ul.  Thus, 25ul of DCF is used in the reaction mixture since this represents a 10-fold dilution.  Set up table (as shown below) and determine the amount of VO2 buffer necessary to make each of the reaction mixtures equal to 250 ul.  (Remember to include a control with only VO2 buffer and DCF reagent as in Well #1 shown below)            
  SS 
       Control 
Mar.23 Mar.25 Mar.29 
  Well #1 Well #2 Well #3 Well #4 
ug mito 0 50 50 50 
ul mito 0.00 11.77 9.80 17.24 
VO2 Buff 225.00 213.23 215.20 207.76 
DCF (50uM) 25 25 25 25 
Total Volume 250 250 250 250 
 4. Once table is complete and volumes for all samples have been determined, place the frozen (already thawed) or fresh mitochondria, VO2 buffer and DCF (500uM) into a 37°C circulating water bath for 5-10 min. 5. Pipette the volume of VO2 buffer required for each of the samples followed by the mitochondrial samples into the appropriate wells of a 96-well plate.  In addition, include a well (usually in the corner well) with only 250 ul of VO2 buffer to monitor temperature (see below). Place the 96-well plate with the VO2 buffer and mitochondria into a 37°C incubator.  Using the YSI temperature probe, place the recording electrode into the well with buffer only and monitor the temperature until 37°C is reached.  During this time, be sure that the KC4 software is set up and that the Biotek plate reader is pre-heating to 37°C. 6. Once mitochondria and buffer have reached temperature (37°C), take the DCF out of the circulating water bath (37°C) and quickly add the DCF to each of the reaction mixtures.   Following addition of DCF, promptly place the plate into the Biotek plate reader for fluorescence measurement and start the KC4 program by pressing READ plate on the upper left portion of the computer screen.  Kinetic program will operate for 1 h and 20 min.   
 
MITOCHONDRIAL PROTEIN IMPORT         Reference: Takahashi and Hood, J. Biol. Chem. (1996) 271, 27285-27291  The majority of nuclear-encoded mitochondrial proteins require a mechanism of import.  Proteins destined for this organelle also require a presequence.  This will provide a 
“passport” containing instructions for the final destination for that protein.  Once the 
protein has reached its final destination, the presequence is cleaved, leaving a “mature” protein.  By taking advantage of this change in protein size, we are able to establish a means by which imported proteins can be discerned.  This can be accomplished by radiolabelling the precursor proteins in vitro then allowing them to be imported.  The 
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samples can be electrophoresed on a polyacrylamide gel and will appear as two bands (precursor and mature) when the gel is exposed to film.  
A. In Vitro Transcription And Translation Note: Steps 1-7 are usually done on the same day. 
1.  Linearize DNA   x Combine the following in an eppendorf: 40 µl DNA at 5 µg/µl (200 µg) 5 µl 10x Enzyme buffer  5 µl Restriction enzyme  
x incubate for 1 hour at 37qC. 
2. Proteinase K- only to be carried out if using miniprep DNA, otherwise skip to step 3 
x Combine the following: 50 µl above 6.7 µl 10X Proteinase K buffer 6.7 µl 5% SDS 7.0 µl PK [1 µg/µl] -- to a final [ ] of 100 µg/ml Note: 1 µg/µl PK should be made on day of experiment by diluting the stock;  20 µg/µl stock PK is kept at in the -20 qC freezer.  
x Incubate for 1 hour at 37qC. 
3. Phenol extraction / ethanol precipitation a) Add appropriate volume of sterile dH2O so that the final volume equals 400 µl. b) Add 400 µl phenol. c) Mix by inversion and spin in microfuge for 30 sec. d) Withdraw and save upper phase. e) Add 400 µl Phenol:Chloroform:Isoamylalcohol (25:24:1, v:v:v). f)  Mix by inversion and spin in microfuge for 30 sec. g) Withdraw and save the upper phase. h) Add 400 µl Chloroform:Isoamylalcohol (24:1, v:v).  i)  Mix by inversion and spin. j) Withdraw and save the upper phase. k)  Add 40 µl 3 M Na Ac (1/10 vols) and 1 ml of -20 qC 100% ethanol (2.5 vols). l) Mix by inversion and precipitate at -70 qC for 30 min (can be left overnight). m)  Spin 10 min. at 4 qC and discard the supernate. n) Gently wash pellet with 400 µl 70% ethanol. o) Spin 3 min. at 4qC, discard the supernate. p) Dessicate pellet. q) Resuspend the pellet in 30-50 µl TE, pH 8.0. 
4. Measure [DNA] 
x Read the O.D. at A260 to determine the concentration of DNA. 
x Dilute the DNA to 0.8 µg/µl in TE (pH 8.0). 
5. Transcription 
x Combine the following in the order indicated: 60.8 µl  plasmid (0.8 µg/µl in TE) 
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8.4 µl dH2O 5.2 µl NTP (10 mM) 10.0 µl ATP (10 mM) 11.6 µl 7-MGG (1 mM) 15.6 µl Mix     5.2 µl RNA guard     4.8 µl of appropriate RNA polymerase 121.6 µl total volume 
x Incubate for 90 min. at the optimum temperature for the polymerase (37 qC for T7, 40 qC for SP6). 
x Note: the reaction can be scaled up or down in volume, provided proportions are maintained. 
6. Phenol extraction / ethanol precipitation 
x Bring volume up to 400 µl with sterile dH2O (using 280 µl) 
x Proceed exactly as described in step 3, above. 
x Resuspend the pellet in 25-40 µl sterile dH2O 
7. Measure [mRNA] 
x Read the O.D. at A260 to determine the concentration of mRNA 
x Dilute mRNA to 2.8 µg/µl in sterile dH2O.  Store at -20 qC in 50 µl aliquots 
B. In Vitro Translation Reference: Promega Technical Manual: “Rabbit Reticulocyte Lysate System”  Part # TM232. 1. Combine the following: Promega lysate  (For 1 reaction -- in µl)  For 10µl of final “lysate” Lysate  64.1%   11.8    6.38 AA(-met)   2.2%     0.4    0.22 st. dH2O 21.6%     3.97    2.15 35S-met   7.2%     1.33    0.72 mRNA   5.4%      1.0    0.54 18.5 µl Notes: i) The Promega manual suggests that lysate should be thawed slowly on ice.  It also suggests that the number of freeze/thaw cycles be limited to two. ii) The volume of mRNA can be adjusted to optimize translational efficiency by altering the dH2O volume accordingly. 2. Incubate for 25-60 min. at 30 qC (note: time may vary with mRNA) 3. Record 35S use (15 µCi/µl). 
C. Protein Import 
Isolated mitochondria (see protocol “MITOISO”) should be resuspended in a resuspension buffer. A sample pipette plan is provided below: (typically 13 lanes can be run on SDS-PAGE gels) SS     IMF Lane 1 2 3 4 5 6 7 8 9 10 11 
---------------------------------------------------------------------------------------------------- time  0 1.5 3 6 10 0 1.5 3 6 10 (min) mito  50---------------------------------->      20-----------------------------------> 
(μg) 
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lysate 5 12------------------------------------------------------------------------------> 
(μl) 
----------------------------------------------------------------------------------------------------- TOTAL  62---------------------------------->        32---------------------------------->  - preincubate both the mitochondria and lysate for 10 minutes @ 300C, then combine lysate  and mitochondria to initiate import reaction.   - incubate @ 300C for the times indicated. -  to recover the mitochondria following import, spin the entire volume through a sucrose  gradient (600 μl) for 15 min at 40C.  - remove the supernate with pasteur pipette into the radioactive waste. -  resuspend pellets in 25 µl breaking buffer. -  add 25 µl lysis buffer and 10 µl BPB. -  denature samples for 5 min. at 95qC, then quick cool on ice. -  apply the samples to an 8% SDS polyacrylamide gel (see “Gel” on disk) and electrophorese overnight at approximately 45 volts.  
D.  Fluorography  1. Remove gel from chamber and cut out the appropriate section of the gel.  Identify the orientation of the gel. 2. Boil the gel in approximately 200 ml of 5% TCA for 5 min. in metal container, over the Bunsen burner in the fume hood. 3. Using a spatula, transfer the gel to a radioactive tupperware container and rinse the gel briefly in dH2O (approximately 30 seconds). 4. Wash in 10 mM Tris-base for 5 min. on shaker (approxiamtely 100 ml). 5. Wash in 1 M salicylic acid for 30 min. on shaker (approximately 100 ml). 6. Dry the gel for 1 hr at 80qC. 7. Combine all wash solutions in the metal container and boil down the liquid.  Let cool and then dispose of in 35S waste. 
  
E.  Solutions for Transcription and Translation  Note: because mRNA is involved in both transcription and translation, sterile conditions should be adhered to at all times.  Use sterile glassware, eppendorfs, dH2O, etc.  Autoclave or sterile filter solutions where indicated.  
10 X Proteinase K buffer  For 10 ml 500 mM NaCl   0.2922g or 5 ml of 5 M NaCl 50 mM EDTA                           0.1861g or 0.5 ml of  0.5 M EDTA, pH 8 100 mM Tris-HCl  0.1576g or 1 ml of 1 M Tris, pH 8 3.5 ml sterile dH2O  -pH to 8.0  
20 mM HEPES   Use 0.4766g/100 ml, pH to 7.0, autoclave.  
1 M HEPES  Use 23.83 g/100ml, pH to 7.9, autoclave.  Store at RT.  
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NTPs   MW(g/mol) For 50 mM (stocks)   CTP                                         483.2                      24.16 mg/ml  GTP                                         523.2                     26.16 mg/ml UTP                                        484.1                      24.21 mg/ml ATP                                        551.1                      27.56 mg/ml Note: These NTPs should be made up in 20 mM HEPES.  Make up 1 ml of each as stock.  Filter each sterile (using sterile acrodisk).  
10 mM NTPs       For 500 µl 10 mM GTP  100 µl of 50 mM GTP stock 10 mM CTP 100 µl of 50 mM CTP stock 10 mM UTP 100 µl of 50 mM UTP stock 20 mM HEPES (pH 7.0)      200 µl of 20 mM HEPES(pH 7.0) - store in 50 µl aliquots at -20 qC  
10 mM ATP       For 500 µl 10 mM ATP       100 µl of 50 mM ATP 20 mM HEPES (pH 7.0) 400 µl of 20 mM HEPES (pH 7.0) - store in 50 µl aliquots at -20 qC  
7-MGG (Pharmacia 27-4635-02) 1 mM stock is made from Pharmacia pellet.  25U is ordered; added to this is 1208 µl of 20 mM HEPES (pH 7.0), yielding a 1 mM stock.  Aliquot into 300 µl,  store at -20 qC.  
Mix 1      For 1200 µl 0.167 M HEPES (pH 7.9)    200 µl of 1 M HEPES (pH 7.9) 0.083 M MgAc2                                                                     100 µl of 1 M MgAc2 1.667 M Kac     500 µl of 4 M KAc 1.667 mM spermidine    100 µl of 20 mM spermidine 0.042 M  DTT 100 µl of 0.5 M DTT  200 µl of dH2O    - store in 100 µl aliquots at -20 qC 
RNA guard -- Pharmacia #27-0815-01 
Lysate  -- Fisher (Promega) L4960 
35S-met -- Amersham SJ-1515 
T7 RNA Polymerase -- Boehringer 881767 (20 U/ μl) 
SP6 RNA Polymerase -- Boehringer 1487671 (20 U/ μl)  
Solutions for Import  
PMSF Prepare stock of 130mM in DMSO (i.e. 22.65 mg PMSF / ml DMSO).  Store at -20 qC.  
Breaking Buffer (can leave up to 1 month)  for 100ml 0.6 M Sorbitol     25 ml of 2.4 M Sorbitol -store at 4 qC 20 mM HEPES     2 ml of 1 M Hepes (pH 7.4) 72 ml dH20  
2.4 M Sorbitol  Use 43.73 g / 100 ml.  Store at 4 qC. 
2.5 M KCl  Use 18.64 g / 100 ml.  Store at 4 qC. 
1 M MgCl2  Use 2.033 g / 10 ml.  Store at 4 qC. 
1 M HEPES (pH 7.4)  Use 238.3 mg/ml, pH to 7.4.  Store at 4 qC.  
Sucrose cushion (make fresh per experiment) for 25 ml 
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0.6 M Sucrose     5 g 0.1 M KCl     1 ml of 2.5 M KCl 2 mM MgCl2     50 µl of 1 M MgCl2  20 mM HEPES     0.5 ml of 1 M HEPES (pH 7.4)  
Solutions for Fluorography  
5% TCA  Use 200g / 4 L 
10 mM Tris-base  Use 4.846 g / 4 L 
1 M Salicylic acid  Use 640.4 g / 4 L 
 
WESTERN BLOTTING           
Reagents: 
1. Acrylamide/Bis-Acrylamide, 30% Solution 37.5:1 (BioShop 10.502) 
a. Store at 4°C 
2. Under Tris Buffer 
a. 1M Tris-HCl, pH 8.8 (60.5g/500ml) 
b. Store at 4°C 
3. Over Tris Buffer 
a. 1M Tris-HCl, pH 6.8 (12.1g/100ml) 
b. Bromophenol Blue (for colour) 
c. Store at 4°C 
4. Ammonium Persulfate (APS) 
a. 10% (w/v) APS in ddH20 (1g/10ml) 
b. Stored at 4°C 
5. Sodium Dodecyl Sulfate (SDS) 
a. 10% (w/v) in ddH20 (1g/10ml) 
b. Store at room temperature 
6. TEMED (Sigma T-9281) 
7. Electrophoresis Buffer, pH 8.3 (10L) 
a. 25mM Tris 30.34g, 192mM Glycine 144g, 0.1% SDS 10g 
b. Volume to 10L with ddH20 
c. Store at room temperature 
8. 6X SDS 
a. Warm 100% glycerol in water bath at 65°C for 30 minutes 
b. Combine 1.2g SDS, 0.06g Bromophenol Blue, 3mls of 1M Tris, pH 6.8 and 1ml 
of ddH20 and stir at 4°C for 5 minutes 
c. Add 3mls of 100% glycerol, stir and aliquot mixture. 
d. Store at -20°C 
e. Add 5% (v/v) ß-mercaptoethanol (Sigma M6250) to 6X SDS just prior to use 
9. tetra-Amyl alcohol ReagentPlus, 99% (Sigma 152463) 
 
Procedure: 
1. Prepare electrophoresis rack: 
a. Clean glass plates thoroughly with soap followed by 95% ethanol then ddH20.  
b. Dry carefully with a kimwipe.  
c. Assemble glass plates as shown below: 
d. Check the seal by adding a small volume of ddH20 then pour off and let dry.  
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2. Prepare separating gels: 
a. Mini Protean 3 Bio-Rad System volumes: 
 
 
 8% 10% 12% 15% 18% 
Acrylamide 2.7 ml 3.3 ml 4.0 ml 5.0 ml 6.0 ml 
ddH20 4.1 ml 3.5 ml 2.8 ml 1.8 ml 0.8 ml 
Under Tris 3.0 ml 3.0 ml 3.0 ml 3.0 ml 3.0 ml 
SDS 100µl 100µl 100µl 100µl 100µl 
APS 100µl 100µl 100µl 100µl 100µl 
TEMED 10µl 10µl 10µl 10µl 10µl 
 
b. Mix the contents of the separating gel without adding APS or TEMED. Stir.  
c. Add APS and TEMED. Stir.  
d. Slowly pour the entire volume of the solution into the space between the two 
plates while keeping plates tilted to prevent bubble formation. 
e.  Add tert-Amyl alcohol to coat top surface of gel solution. 
f. Allow 30 minutes for gel polymerization.  
g. Remove tert-Amyl alcohol by pouring it off and remove any remainder with a 
kimwipe. Rinse with ddH20. 
 
3. Prepare stacking gel: 
a. For a single mini gel use the following volumes: 
 
Acrylamide 500 µl 
Over Tris 625 µl 
ddH20 3.75 ml 
SDS 50 µl 
APS 50 µl 
TEMED 7.5 µl 
 
b. Mix the contents of the stacking gel without adding APS or TEMED. Stir.  
c. Add APS and TEMED. Stir.  
d. Using a Pasteur pipette slowly add the entire volume from the beaker in between 
the plates.  
e. Add comb for desired number of wells. 
f. Allow 30 minutes for gel polymerization. 
 
4. Prepare samples: 
a. Turn on the block heater to 95ºC.  
b. Pipette required volume of sample into new eppendorf with same amount of lysis 
buffer and 5 µl of sample dye. Keep samples on ice until all samples are prepared 
(use pipette plan). 
c. Briefly spin each sample to bring volume to the bottom of the eppendorf. 
d. Incubate each sample at 95 ºC for 5 minutes in the heating block to denature the 
proteins.  
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e. Briefly spin again to return volume to the bottom of the eppendorf. 
 
5. Assemble Mini-PROTEAN gel caster system: 
a. See images below 
b. If you are only running one gel a plastic rectangular pseudo plate must be 
clamped on the other side of the caster.  
c. Fill with electrophoresis buffer between the plates and outside of the plates in the 
chamber.  
d. Slowly remove the comb using both hands (one on each side) by pulling the comb 
straight upwards.  
e. Fix any wells that are deformed using a small spatula.  
f. Clean out the wells using a syringe filled with electrophoresis buffer.  
g. Withdraw the entire volume of the sample using a Hamilton syringe. Inject 
volume slowly into the bottom of the well.  
 
6. Gel electrophoresis  
a. Immediately after all samples are loaded place the lid on the gel chamber. 
b. Place positive and negative plugs into the power supply and turn on power supply.  
c. Set power supply to 120V. Gel will run for ~2 hours depending on percent gel 
made. 
d. When the bromophenol blue has run off the bottom of the gel (or when gel has 
separated the desire amount) turn off the power supply. Remove plugs from 
power supply and remove lid. 
e. Prepare for electrotransfer of proteins from the gel to nitrocellulose membrane.  
 
Western Blotting-Transfer and Immunodetection: 
 
Reagents: 
1. Transfer Buffer 
a. 0.025M Tris-HCl pH 8.3  12.14g 
b. 0.15M Glycine   45.05g 
c. 20% Methanol  800ml 
d. make up to 4L with ddH20 
e. store at 4°C 
2. Ponceau S stain 
a. 0.1% (w/v) Ponceau S  
b. 0.5% (v/v) Acetic Acid 
c. Store at room temperature 
3. Wash Buffer 
a. Tris-HCl pH 7.5  12g 
b. NaCl   58.5g 
c. 0.1% Tween  10ml 
d. Store at room temperature 
4. Blocking Solution 
a. 5% (w/v) skim milk power in wash buffer OR 
b. 5% (w/v) BSA in wash buffer 
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5. Enhanced Chemiluminescence Fluid (ECL; Santa Cruz sc-2048) 
6. Film/Developer/Fixer 
 
Procedure: 
1. Transfer Procedure 
a. Remove electrophoresis plates from chamber and separate the plates. 
b. Cut away unnecessary parts of the gel using a spatula and measure remaining gel 
size. 
c. Using a paper cutter cut 6 pieces of Whatman paper per gel to the same size as the 
gel. Wearing gloves cut nitrocellulose membrane (GE Healthcare RPN303D) to 
the dimensions of the gel.  
d. Assemble Whatman paper, nitrocellulose memebrane and gel as shown above: 
e. Close the cassette and place in the transfer chamber with the black side of the 
cassette facing the back side of the chamber.  
f. Place ice pack in the chamber. 
g. Place lid on the chamber and connect the leads to the power supply.  
h. Turn on the power supply and run at 120V for 2 hours. This can vary depending 
on the size of the protein of interest. 
 
2. Removal of transfer membrane: 
a. Turn off the power supply and disconnect leads from the power supply then 
remove the lid from the chamber. 
b. Remove the cassette from the chamber.  
c. With gloves on, remove the Whatman paper and gel and place the nitrocellulose 
membrane in a plastic dish.  
d. Add Ponceau S stain on the membrane and gently swirl.  
e. Drain off the remaining Ponceau S and save for reuse. 
f. Rinse the membrane with ddH20 to reduce the red background. Wrap membrane 
in saran wrap and scan image. 
g. Cut the membrane while protein bands are still visible at the desired molecular 
weight. 
h. Rotate membrane at room temperature in wash buffer until remaining Ponceau S 
has been removed. 
i. Incubate membrane for 1 hour with rotation in blocking solution.  
j. Incubate membrane with desired antibody diluted in blocking solution overnight 
at 4ºC. Membrane is placed face up into the solution on a glass plate covered in 
parafilm. To maintain a moist environment overnight, wet a small kimwipe and 
form it into a ball and place in each corner of the dish. Cover the dish with saran 
wrap. 
 
3. Immunodetection 
a. Wash the blots in wash buffer with gentle rotation for 5 minutes 3X. 
b. Incubate the blots for 1 hour in room temperature with the appropriate secondary 
antibody diluted in blocking solution. 
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c. Membrane is placed face up in solution on a glass plate covered with parafilm. 
Place moist kimwipes in each corner of the dish and cover the dish with saran 
wrap. 
d. Following the incubation, wash the membrane 3X for 5 minutes with wash buffer. 
 
4. Enhanced Chemiluminescence Detection 
a. Mix ECL fluids “A” and “B” in a 1:1 ratio in a disposable Rohr tube. 
b. Place blots on saran wrap face up and apply ECL solution for 2 minutes.  
c. Dab off excess ECL on a kimwipe and place blots face down on a fresh piece of 
saran wrap and wrap tightly. 
d. Expose blot to film (time will vary depending on protein and antibody).  
e. Place film into developer (time will vary). 
f. Once image appears place film into fixer for 2 minutes. Wash with fresh water 
when complete. 
 
RNA ISOLATION, REVERSE TRANSCRIPTION AND QPCR      
RNA Isolation 
Procedure:  
1) Homogenize (approximately 30 sec. @ 30-40% power) tissues (200 mg) at  
 30% in 2 ml Tri-reagent in a 13 ml Sarstedt tube; 
OR 
Homogenize (approximately 30 sec. @ 30-40% power) tissues (200 mg) at  
30% in 1.25 ml solution D + 1.25 ml phenol + 0.125 ml 2M sodium acetate  
(pH 4.0) in a 13 ml Sarstedt tube 
**Note: The homogenizer must be sterilized in 0.1M NaOH and rinsed in sterile 
water prior to use.  Rinse in sterile water between samples. 
2) Let stand for 5 min at room temperature; 
3) Add 0.4 ml chloroform and shake vigorously for 15 sec, let stand for 2-3 min at room 
temperature; 
4) Spin at 12,000 g for 15 min at 4°C; 
5) Transfer aqueous phase to 13 ml Sarstedt tube; 
6) Add 1 ml isopropanol, gently shake, and allow precipitation of RNA for 5-10 min at 
room temperature; 
7) Spin at 12,000 g for 10 min at 4°C; 
8) Remove supernatant and add 0.7 ml 75% ethanol; 
 
9) Transfer RNA to eppendorf tube; 
10) Rinse 13 ml Sarstedt tube with 0.3 ml 70% ethanol, add to eppendorf tube and mix by 
vortexing; 
11) Spin 5 min in eppendorf centrifuge at 4°C; 
12) Discard supernatant; 
13) Dry pellet under a vacuum in dessicator (DO NOT DRY PELLET WITH 
CENTRIFUGATION UNDER A VACUUM); 
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14) Dissolve pellet in 50-200 μl sterile distilled DEPC water and measure absorbance at 260 
nm and 280 nm. 
Reagents: 
1. Solution D  (Denaturing solution) 
4 M Guanidinium Thiocyanate     125 g  
25 mM of 1 M stock NaCitrate (pH 7.0)   6.6 ml 
N-Lauroyl Sarcosine;Sigma L-5125 (0.5% Sarcosyl) 1.32 g  
ddH2O        160 ml  
**Note: make up solution D and store at RT for up to 3 months.  On the day of 
the experiment, mix 50 ml of Solution D with 0.36 ml of beta-Mercaptoethanol 
(0.1 M b-MEtOH) 
2. Phenol (Nucleic acid grade) 
a) Melt solid phenol at 68 °C (cap loose) in H2O; 
b) Add 0.25 g 8-hydroxyquinoline to 250 ml of phenol, mix; 
c) Add 250 ml 1.0 M Tris HCl (pH 8.0) and stir overnight at 4 °C covered in foil 
d) Remove supernatant;  
e) Add 250 ml 0.1 M Tris-HCl containing 0.2 % b-MEtOH (0.178 ml/100 ml for S.G. = 
1.12) and mix thoroughly;  
f) Allow solution to settle and remove supernatant; 
g) Repeat 2 more times as above or until pH of phenol is > 7.6 (test with pH paper). 
h) Store in 25-50 ml aliquots at -20 °C. 
3. 2.0 M Na Acetate (pH 4.0) 
10.88 g/100 ml sterile H2O 
4. 75% ethanol in sterile H2O  
(75 ml ethanol + 25 ml dH2O) 
 
Reverse Transcription, First Strand cDNA Synthesis 
 
First-strand cDNA synthesis is performed following the manufacturer's recommendations 
that are outlined below: 
 
Reagents: 
 
1. total RNA (isolated as described) 
2. Oligo(dT)12-18 
3. 10 mM dNTPs (dATP, dTTP, dCTP, dGTP; 10 mM each) 
4. Sterile ddH20  
5. RNAse OUT (40 units/ µl) 
6. 0.1 M DTT 
7. 5X First-strand Buffer 
8. SuperScript II RT 
 *Note: All reagents except RNA are supplied with the SSII kit from Invitrogen. 
 
Procedure: 
 
1. Add following components to a nuclease/ RNA-free 500 µl eppendorf: 
   Oligo(dT)12-18   1µl 
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   1 µg of RNA   x µl 
   dNTP mix    1 µl 
   Sterile ddH20   to 20 µl 
2. Heat mixture to 65°C for 5 minutes and quick chill on ice.  Collect the contents with a 
quick spin in a tabletop microcentrifuge and then add: 
   5X First-strand buffer  4 µl 
   0.1 M DTT   2 µl 
   RNAse OUT   1 µl 
3. Mix contents of tube gently and incubate at 42°C for 2 minutes. 
4. Add 1 µl (200 units) of Superscript II RT and mix by pipetting gently up and down. 
5. Incubate at 42°C for 50 minutes. 
6. Inactivate the reaction by heating at 70°C for 15 minutes. 
7. cDNA is ready for use in PCR amplification.  
 
Polymerase Chain Reaction (PCR) 
 
1) 2 ug of RNA is converted to 2 ug of cDNA (STOCK cDNA)     
2) We dilute STOCK cDNA to 1:30 (2 uL STOCK cDNA added to 58 uL nuclease-free 
ddH₂O) 
3) We add 4 μL of diluted cDNA, thus loading 10 μg cDNA per well 
4) For SYBR Green analyses, primers were optimized, diluted and mixed with PerfeCTa 
SYBR® Green SuperMix, ROX Master Mix and nuclease-free ddH₂O 
5) Total reaction volumes were always 25 μL 
6) Samples must be duplicated to ensure accuracy. 
7) Use negative wells to monitor contamination, using nuclease-free ddH₂O in place of 
cDNA. 
8) Check for nonspecific amplification and primer dimers by analyzing melt curves 
 
PROTEIN RELEASE AND PEPTIDE ISOLATION        
 
Background:  Mitochondria are a primary source of reactive oxygen species (ROS) which have 
been shown to have both direct and indirect effects on apoptosis.  ROS cause damage by binding 
to molecules and changing their conformation and function.  Specifically, ROS have been shown 
to facilitate the opening of the mtPTP, and induce the release of pro-apoptotic products from the 
mitochondria.  Release of either pro-apoptotic proteins cytochrome c and/or apoptosis-inducing 
factor (AIF) from the mitochondria triggers apoptotic cellular death (albeit acting through 
different pathways).  These proteins are released from the mitochondrion through a specialized 
pore in the mitochondrial membrane termed the mitochondrial permeability transition pore 
(mtPTP).  Using isolated mitochondria, release of these pro-apoptotic molecules can be induced 
by exogenous treatment with reactive oxygen species (ROS)-agents, such as H2O2.  In addition, 
it has been shown that H202 treatment, in conjunction with a ferrous ion donor, catalyzes a 
reaction that results in the production of a second more damaging ROS, the hydroxyl radical OH- 
(this is due to the Fenton reaction-H2O2 + Fe2+ = OH- + OH• + Fe3+).  Thus, the combination of 
H2O2 and FeSO4 (dissociating in solution to form ferrous ions) causes pro-apoptotic release from 
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the mitochondrion. Experimentally, release of these pro-apoptotic products can be assessed by 
treating isolated mitochondria with a combination of H2O2/FeSO4 for a set duration of time 
(60min), followed by centrifugation of the reaction mixture to fractionate mitochondria (pellet) 
from the supernate. The supernate fraction is then used for Western blot analysis of cytochrome c 
and AIF.  
 
 
Resuspension Medium (pH-7.4):  
10 mM HEPES 
0.25 mM Sucrose 
10 mM Sodium Succinate 
2.5 mM K2HPO4 
1 mM DTT 
Reagents: 
Stock Concentrations 
100 uM H2O2  
100mM FeSO4 (278mg/10mls) 
10mM Cyclosporin A in DMSO 
 
Procedure 
1. SS and IMF mitochondria are isolated and resuspended as described in the mitochondrial 
isolation protocol. Determine the concentration of samples using Bradford method.   
2. Prepare 6 eppendorf tubes per sample. Follow the pipette plan for the various conditions, 
adding the mitochondria first, resuspension buffer, H2O2, FeSO4, then Cyclosporin A.  
 
Lanes 1 2 3 4 5 6 
Sample Name AO74 AO74 AO74 AO74 AO74 AO74 
Sample Description IMF IMF IMF IMF IMF IMF 
Protein for 5 ul 58.15 58.15 58.15 58.15 58.15 58.15 
Protein ug/ul 11.63 11.63 11.63 11.63 11.63 11.63 
Total Protein 
(ug) 125 10.75 10.75 10.75 10.75 10.75 10.75 
H2O2 0.00 2.50 2.50 0.00 2.50 2.50 
FeSO4 0.00 0.00 1.00 0.00 0.00 1.00 
Cyclosporin A 0.00 0.00 0.00 1.00 1.00 1.00 
Resusp. Buffer 39.25 36.75 35.75 38.25 35.75 34.75 
Total 50.0 50.0 50.0 50.0 50.0 50.0 
 
3. Incubate reaction mixtures for 60min at 30˚C. 
4. Centrifuge eppendorfs for 5min at 14,000g (4˚C) to pellet the mitochondria. 
5. Following centrifugation, carefully extract the entire supernate fraction from the 
mitochondrial pellet (NOTE:do not disrupt mitochondrial pellet) and transfer to 
another set of pre-labelled eppendorf tubes. 
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6. The entire supernatant volume is transferred to a Spin-X Concentrator (Corning) and 
centrifuged for 15 mins at 15,000g at room temperature. This separates released fraction 
by size, allowing the collection of all released products under 3 kDa. Transfer the 
separated fraction into pre-labelled eppendorfs, keep on ice.  
7. Measure the concentration of protein using a spectrophotometer (NanoDrop 2000, 
Thermo Fisher) at 280nm 
8. Store in -80ºC. 
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